Psyllid ID: psy14531
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 222 | ||||||
| 328713737 | 554 | PREDICTED: locomotion-related protein Hi | 0.900 | 0.361 | 0.469 | 4e-51 | |
| 189235022 | 523 | PREDICTED: similar to hikaru genki CG204 | 0.891 | 0.378 | 0.459 | 1e-50 | |
| 307167690 | 475 | Locomotion-related protein Hikaru genki | 0.896 | 0.418 | 0.459 | 2e-50 | |
| 157107150 | 881 | hypothetical protein AaeL_AAEL004725 [Ae | 0.905 | 0.228 | 0.443 | 5e-48 | |
| 350396746 | 487 | PREDICTED: locomotion-related protein Hi | 0.896 | 0.408 | 0.448 | 6e-48 | |
| 345484402 | 470 | PREDICTED: locomotion-related protein Hi | 0.896 | 0.423 | 0.434 | 8e-48 | |
| 340715609 | 485 | PREDICTED: locomotion-related protein Hi | 0.896 | 0.410 | 0.441 | 1e-47 | |
| 340715607 | 488 | PREDICTED: locomotion-related protein Hi | 0.896 | 0.407 | 0.441 | 1e-47 | |
| 195442095 | 954 | GK17970 [Drosophila willistoni] gi|19416 | 0.914 | 0.212 | 0.413 | 1e-46 | |
| 195581836 | 924 | GD10090 [Drosophila simulans] gi|1941927 | 0.887 | 0.213 | 0.416 | 3e-46 |
| >gi|328713737|ref|XP_003245168.1| PREDICTED: locomotion-related protein Hikaru genki-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 206 bits (525), Expect = 4e-51, Method: Compositional matrix adjust.
Identities = 100/213 (46%), Positives = 132/213 (61%), Gaps = 13/213 (6%)
Query: 10 QGQWSGEVPTCQQIICPKIVVENPYLTLVEQNNTYRGHAIFQCSWGYQLKGPPDIVCQKN 69
G WS P C + CP I V++ L +VE N+TY A F+C+WG+Q+ G I C +
Sbjct: 355 SGDWSNSPPDCIMVKCPPISVDDSRLIMVEYNDTYGKRAAFKCAWGFQMSGVNSIECLAD 414
Query: 70 GSWSGAIPECNAFFFFFFFFFFNPVHCPVPALPLNGHLIEDPTGGPYRVGAILQFACNDR 129
+WS IP C CP P +PLNG LIED G + VG+++QF+C ++
Sbjct: 415 STWSHRIPTCTEIL------------CPPPVVPLNGLLIEDSAPGRHVVGSVVQFSCGEK 462
Query: 130 HHLLGEETIVCTETGRWSRAPPRCKARCEYPGEPQNGKIIPLKFFYDPGDHIQVTCNDGY 189
H L+G+ ++VCTE G WS + P CKARCEYPGEP NG+IIPLKF+Y PGD +++TC GY
Sbjct: 463 HQLIGKPSMVCTENGTWSHSTPYCKARCEYPGEPPNGRIIPLKFWYVPGDKLKITCLAGY 522
Query: 190 VKPLDITPTSGPYCQSDGTWSLDIPHCTNYTDV 222
V PL + S P C DGTWS +P C YT+V
Sbjct: 523 VLPLPLE-ASPPVCLGDGTWSHTLPECIQYTNV 554
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189235022|ref|XP_971621.2| PREDICTED: similar to hikaru genki CG2040-PB [Tribolium castaneum] gi|270004865|gb|EFA01313.1| hypothetical protein TcasGA2_TC003245 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|307167690|gb|EFN61193.1| Locomotion-related protein Hikaru genki [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
| >gi|157107150|ref|XP_001649645.1| hypothetical protein AaeL_AAEL004725 [Aedes aegypti] gi|108879626|gb|EAT43851.1| AAEL004725-PA [Aedes aegypti] | Back alignment and taxonomy information |
|---|
| >gi|350396746|ref|XP_003484650.1| PREDICTED: locomotion-related protein Hikaru genki-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
| >gi|345484402|ref|XP_001604226.2| PREDICTED: locomotion-related protein Hikaru genki-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
| >gi|340715609|ref|XP_003396303.1| PREDICTED: locomotion-related protein Hikaru genki-like isoform 2 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
| >gi|340715607|ref|XP_003396302.1| PREDICTED: locomotion-related protein Hikaru genki-like isoform 1 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
| >gi|195442095|ref|XP_002068795.1| GK17970 [Drosophila willistoni] gi|194164880|gb|EDW79781.1| GK17970 [Drosophila willistoni] | Back alignment and taxonomy information |
|---|
| >gi|195581836|ref|XP_002080736.1| GD10090 [Drosophila simulans] gi|194192745|gb|EDX06321.1| GD10090 [Drosophila simulans] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 222 | ||||||
| FB|FBgn0010114 | 958 | hig "hikaru genki" [Drosophila | 0.900 | 0.208 | 0.422 | 3.4e-50 | |
| FB|FBgn0032797 | 1678 | CG10186 [Drosophila melanogast | 0.878 | 0.116 | 0.324 | 1.5e-26 | |
| MGI|MGI:1928849 | 3567 | Svep1 "sushi, von Willebrand f | 0.824 | 0.051 | 0.3 | 2.4e-18 | |
| UNIPROTKB|F1SND0 | 3573 | SVEP1 "Uncharacterized protein | 0.608 | 0.037 | 0.355 | 1.1e-24 | |
| RGD|1588987 | 3564 | Svep1 "sushi, von Willebrand f | 0.824 | 0.051 | 0.3 | 2.4e-18 | |
| UNIPROTKB|P0C6B8 | 3564 | Svep1 "Sushi, von Willebrand f | 0.824 | 0.051 | 0.3 | 2.4e-18 | |
| UNIPROTKB|Q4LDE5 | 3571 | SVEP1 "Sushi, von Willebrand f | 0.828 | 0.051 | 0.272 | 8.5e-15 | |
| UNIPROTKB|F1MNH3 | 3573 | SVEP1 "Uncharacterized protein | 0.743 | 0.046 | 0.324 | 5.5e-17 | |
| UNIPROTKB|F1Q0A7 | 3253 | SVEP1 "Uncharacterized protein | 0.639 | 0.043 | 0.317 | 7.6e-15 | |
| UNIPROTKB|J9NWK3 | 3569 | SVEP1 "Uncharacterized protein | 0.639 | 0.039 | 0.317 | 8.4e-15 |
| FB|FBgn0010114 hig "hikaru genki" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 3.4e-50, Sum P(2) = 3.4e-50
Identities = 92/218 (42%), Positives = 133/218 (61%)
Query: 8 VSQGQWSGEVPTCQQIICPKIVVENPYLTLVEQNNTYRGHAIFQCSWGYQLKGPPDIVCQ 67
++ G WS PTC I CP++ +++P+L+L+E N + G A+F+C WG++L GP + C+
Sbjct: 756 LASGNWSSPTPTCHAIQCPRLELDDPHLSLIELNTSAWGRAVFKCQWGFKLTGPAQLDCE 815
Query: 68 KNGSWSGAIPECNAXXXXXXXXXXNPVHCPVPALPLNGHLIEDPTGGPYR---VGAILQF 124
+G WSG +P C + C +P PLNG + T R VGA++ F
Sbjct: 816 PSGVWSGPVPRCKV------------IQCVMPVAPLNGRI--GGTSLSQRRLTVGALVTF 861
Query: 125 ACNDRHHLLGEETIVCTETGRWSRAPPRCKARCEYPGEPQNGKIIPLKFFYDPGDHIQVT 184
+CND H L+GE +I+CTE G+WS +PP CK++C YPG+P NG I PLKF YD GD++ V
Sbjct: 862 SCNDGHSLVGESSIICTENGQWSHSPPFCKSQCPYPGDPPNGLIAPLKFNYDAGDYLSVQ 921
Query: 185 CNDGYVKPLDITPTSGPYCQSDGTWSLDIPHCTNYTDV 222
C G+V+ + P P CQ DG WS +P C +Y +V
Sbjct: 922 CRPGFVQSYE-GPPERPKCQPDGRWSGPMPKCKSYEEV 958
|
|
| FB|FBgn0032797 CG10186 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
| MGI|MGI:1928849 Svep1 "sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1SND0 SVEP1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| RGD|1588987 Svep1 "sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P0C6B8 Svep1 "Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q4LDE5 SVEP1 "Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1MNH3 SVEP1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1Q0A7 SVEP1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|J9NWK3 SVEP1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 222 | |||
| cd00033 | 57 | cd00033, CCP, Complement control protein (CCP) mod | 6e-12 | |
| PHA02817 | 225 | PHA02817, PHA02817, EEV Host range protein; Provis | 6e-12 | |
| smart00032 | 56 | smart00032, CCP, Domain abundant in complement con | 2e-10 | |
| PHA02639 | 295 | PHA02639, PHA02639, EEV host range protein; Provis | 8e-09 | |
| cd00033 | 57 | cd00033, CCP, Complement control protein (CCP) mod | 1e-08 | |
| smart00032 | 56 | smart00032, CCP, Domain abundant in complement con | 2e-08 | |
| smart00032 | 56 | smart00032, CCP, Domain abundant in complement con | 2e-08 | |
| pfam00084 | 56 | pfam00084, Sushi, Sushi domain (SCR repeat) | 2e-08 | |
| PHA02927 | 263 | PHA02927, PHA02927, secreted complement-binding pr | 4e-08 | |
| cd00033 | 57 | cd00033, CCP, Complement control protein (CCP) mod | 8e-08 | |
| PHA02639 | 295 | PHA02639, PHA02639, EEV host range protein; Provis | 2e-07 | |
| PHA02927 | 263 | PHA02927, PHA02927, secreted complement-binding pr | 5e-07 | |
| PHA02927 | 263 | PHA02927, PHA02927, secreted complement-binding pr | 2e-06 | |
| PHA02817 | 225 | PHA02817, PHA02817, EEV Host range protein; Provis | 1e-05 | |
| pfam00084 | 56 | pfam00084, Sushi, Sushi domain (SCR repeat) | 1e-05 | |
| pfam00084 | 56 | pfam00084, Sushi, Sushi domain (SCR repeat) | 2e-05 | |
| PHA02831 | 268 | PHA02831, PHA02831, EEV host range protein; Provis | 4e-05 | |
| PHA02954 | 317 | PHA02954, PHA02954, EEV membrane glycoprotein; Pro | 9e-05 | |
| PHA02639 | 295 | PHA02639, PHA02639, EEV host range protein; Provis | 3e-04 | |
| PHA02817 | 225 | PHA02817, PHA02817, EEV Host range protein; Provis | 0.002 |
| >gnl|CDD|153056 cd00033, CCP, Complement control protein (CCP) modules (aka short consensus repeats SCRs or SUSHI repeats) have been identified in several proteins of the complement system | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-12
Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 2/59 (3%)
Query: 96 CPVPALPLNGHLIEDPTGGPYRVGAILQFACNDRHHLLGEETIVCTETGRWSRAPPRCK 154
CP P +P NG + + G Y G+ + ++CN+ + L+G TI CTE G WS PP C+
Sbjct: 1 CPPPPVPENGTVT--GSKGSYSYGSTVTYSCNEGYTLVGSSTITCTENGGWSPPPPTCE 57
|
SUSHI repeats (short complement-like repeat, SCR) are abundant in complement control proteins. The complement control protein (CCP) modules (also known as short consensus repeats SCRs or SUSHI repeats) contain approximately 60 amino acid residues and have been identified in several proteins of the complement system. Typically, 2 to 4 modules contribute to a binding site, implying that the orientation of the modules to each other is critical for function. Length = 57 |
| >gnl|CDD|165167 PHA02817, PHA02817, EEV Host range protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|214478 smart00032, CCP, Domain abundant in complement control proteins; SUSHI repeat; short complement-like repeat (SCR) | Back alignment and domain information |
|---|
| >gnl|CDD|165022 PHA02639, PHA02639, EEV host range protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|153056 cd00033, CCP, Complement control protein (CCP) modules (aka short consensus repeats SCRs or SUSHI repeats) have been identified in several proteins of the complement system | Back alignment and domain information |
|---|
| >gnl|CDD|214478 smart00032, CCP, Domain abundant in complement control proteins; SUSHI repeat; short complement-like repeat (SCR) | Back alignment and domain information |
|---|
| >gnl|CDD|214478 smart00032, CCP, Domain abundant in complement control proteins; SUSHI repeat; short complement-like repeat (SCR) | Back alignment and domain information |
|---|
| >gnl|CDD|215703 pfam00084, Sushi, Sushi domain (SCR repeat) | Back alignment and domain information |
|---|
| >gnl|CDD|222943 PHA02927, PHA02927, secreted complement-binding protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|153056 cd00033, CCP, Complement control protein (CCP) modules (aka short consensus repeats SCRs or SUSHI repeats) have been identified in several proteins of the complement system | Back alignment and domain information |
|---|
| >gnl|CDD|165022 PHA02639, PHA02639, EEV host range protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|222943 PHA02927, PHA02927, secreted complement-binding protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|222943 PHA02927, PHA02927, secreted complement-binding protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165167 PHA02817, PHA02817, EEV Host range protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|215703 pfam00084, Sushi, Sushi domain (SCR repeat) | Back alignment and domain information |
|---|
| >gnl|CDD|215703 pfam00084, Sushi, Sushi domain (SCR repeat) | Back alignment and domain information |
|---|
| >gnl|CDD|165176 PHA02831, PHA02831, EEV host range protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165263 PHA02954, PHA02954, EEV membrane glycoprotein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165022 PHA02639, PHA02639, EEV host range protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165167 PHA02817, PHA02817, EEV Host range protein; Provisional | Back alignment and domain information |
|---|
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 222 | |||
| PHA02927 | 263 | secreted complement-binding protein; Provisional | 100.0 | |
| PHA02639 | 295 | EEV host range protein; Provisional | 100.0 | |
| PHA02927 | 263 | secreted complement-binding protein; Provisional | 100.0 | |
| PHA02954 | 317 | EEV membrane glycoprotein; Provisional | 99.98 | |
| PHA02831 | 268 | EEV host range protein; Provisional | 99.97 | |
| PHA02639 | 295 | EEV host range protein; Provisional | 99.95 | |
| PHA02831 | 268 | EEV host range protein; Provisional | 99.95 | |
| PHA02954 | 317 | EEV membrane glycoprotein; Provisional | 99.95 | |
| PHA02817 | 225 | EEV Host range protein; Provisional | 99.93 | |
| PHA02817 | 225 | EEV Host range protein; Provisional | 99.91 | |
| cd00033 | 57 | CCP Complement control protein (CCP) modules (aka | 99.28 | |
| smart00032 | 57 | CCP Domain abundant in complement control proteins | 99.27 | |
| PF00084 | 56 | Sushi: Sushi domain (SCR repeat); InterPro: IPR000 | 99.26 | |
| cd00033 | 57 | CCP Complement control protein (CCP) modules (aka | 99.26 | |
| smart00032 | 57 | CCP Domain abundant in complement control proteins | 99.24 | |
| PF00084 | 56 | Sushi: Sushi domain (SCR repeat); InterPro: IPR000 | 99.22 | |
| PF14704 | 152 | DERM: Dermatopontin | 92.6 | |
| smart00008 | 70 | HormR Domain present in hormone receptors. | 88.61 | |
| PF02793 | 66 | HRM: Hormone receptor domain; InterPro: IPR001879 | 86.87 | |
| smart00008 | 70 | HormR Domain present in hormone receptors. | 84.77 |
| >PHA02927 secreted complement-binding protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=261.60 Aligned_cols=191 Identities=27% Similarity=0.623 Sum_probs=168.4
Q ss_pred CceEeccCCccCCCCCeeEEeeCCCCcc-CCCeEEeccCCcccccEEEEEcCCCCeEeCCCceEeCCCC----eeeCCCC
Q psy14531 3 HPVFRVSQGQWSGEVPTCQQIICPKIVV-ENPYLTLVEQNNTYRGHAIFQCSWGYQLKGPPDIVCQKNG----SWSGAIP 77 (222)
Q Consensus 3 ~~~~c~~~g~Ws~~~p~C~~~~C~~p~~-~ng~~~~~~~~~~~g~~~~~~C~~gy~l~G~~~~~C~~~g----~W~~~~p 77 (222)
..++|+.+| |+. .|.|+++.|+.|+. +||.+.. ..+.+|++|+|+|++||.|.|...++|+.++ +|+.+.|
T Consensus 66 ~~~~C~~~g-Ws~-~p~C~~~~C~~p~~i~NG~~~~--~~~~~G~~v~y~C~~Gy~l~G~~~~~C~~~~~g~~~Ws~~~P 141 (263)
T PHA02927 66 IYAKCTGTG-WTL-FNQCIKRRCPSPRDIDNGQLDI--GGVDFGSSITYSCNSGYQLIGESKSYCELGSTGSMVWNPEAP 141 (263)
T ss_pred cEEEecCCC-CCC-CCcEEeCCCcCCCCCCCCEEeC--CCccCCCEEEEECCCCCEEcCCCeeEEEeCCCCcceECCCCC
Confidence 357899877 995 68999999999987 9999875 4578999999999999999999999998753 7999999
Q ss_pred ceeccceeeeecccccccCCCCCCCCCceEEeCCCCCCcCCCCEEEEEcCCCCEEcCCCeEEeCcCCeeeCCCCcee-ec
Q psy14531 78 ECNAFFFFFFFFFFNPVHCPVPALPLNGHLIEDPTGGPYRVGAILQFACNDRHHLLGEETIVCTETGRWSRAPPRCK-AR 156 (222)
Q Consensus 78 ~C~~~~~~~~~~~~~~~~C~~p~~~~~g~~~~~~~~~~~~~g~~~~~~C~~gy~~~g~~~~~C~~~g~Ws~~~p~C~-~~ 156 (222)
.|+. +.|+.|+.+.||.+.. ....|.+|++|+|.|+.||.|.|...++|+ +|+|+. +|.|+ +.
T Consensus 142 ~C~~------------~~C~~P~~~~nG~~~~--~~~~y~~g~~v~y~C~~Gy~l~G~~~~~C~-~G~Ws~-~P~C~~v~ 205 (263)
T PHA02927 142 ICES------------VKCQSPPSISNGRHNG--YEDFYTDGSVVTYSCNSGYSLIGNSGVLCS-GGEWSD-PPTCQIVK 205 (263)
T ss_pred cccc------------ccCCCCCCCCCcEEcC--CcccccCCCEEEEECCCCCEECCCCeeEEC-CCccCC-CCeEeEeE
Confidence 9999 8999999999998753 245688999999999999999999999997 899997 79999 79
Q ss_pred CCCCCCCCCeEEec-CccccCCCCeEEEEcCCCCeeccCCCCCCcceeCCCCcccCCCCceee
Q psy14531 157 CEYPGEPQNGKIIP-LKFFYDPGDHIQVTCNDGYVKPLDITPTSGPYCQSDGTWSLDIPHCTN 218 (222)
Q Consensus 157 C~~p~~~~~g~~~~-~~~~~~~g~~v~y~C~~gy~~~~~~~~~~~~~C~~~G~W~~~~p~C~~ 218 (222)
|..|. +.||.+.. .+..|.+|++|+|.|++||.+.|+ ..++|+.+|+|++++|+|++
T Consensus 206 C~~P~-i~ng~~~~~~k~~y~~g~~v~y~C~~Gy~l~G~----~~~~C~~~g~Ws~~~P~C~~ 263 (263)
T PHA02927 206 CPHPT-ISNGYLSSGFKRSYSYNDNVDFKCKYGYKLSGS----SSSTCSPGNTWQPELPKCVR 263 (263)
T ss_pred CcCCC-CCCCEEecCCCCccccCCEEEEECCCCCeEcCC----CCeEECCCCEECCCCCeecC
Confidence 99874 67887764 356788999999999999999998 78999999999999999974
|
|
| >PHA02639 EEV host range protein; Provisional | Back alignment and domain information |
|---|
| >PHA02927 secreted complement-binding protein; Provisional | Back alignment and domain information |
|---|
| >PHA02954 EEV membrane glycoprotein; Provisional | Back alignment and domain information |
|---|
| >PHA02831 EEV host range protein; Provisional | Back alignment and domain information |
|---|
| >PHA02639 EEV host range protein; Provisional | Back alignment and domain information |
|---|
| >PHA02831 EEV host range protein; Provisional | Back alignment and domain information |
|---|
| >PHA02954 EEV membrane glycoprotein; Provisional | Back alignment and domain information |
|---|
| >PHA02817 EEV Host range protein; Provisional | Back alignment and domain information |
|---|
| >PHA02817 EEV Host range protein; Provisional | Back alignment and domain information |
|---|
| >cd00033 CCP Complement control protein (CCP) modules (aka short consensus repeats SCRs or SUSHI repeats) have been identified in several proteins of the complement system | Back alignment and domain information |
|---|
| >smart00032 CCP Domain abundant in complement control proteins; SUSHI repeat; short complement-like repeat (SCR) | Back alignment and domain information |
|---|
| >PF00084 Sushi: Sushi domain (SCR repeat); InterPro: IPR000436 Sushi domains are also known as Complement control protein (CCP) modules, or short consensus repeats (SCR), exist in a wide variety of complement and adhesion proteins | Back alignment and domain information |
|---|
| >cd00033 CCP Complement control protein (CCP) modules (aka short consensus repeats SCRs or SUSHI repeats) have been identified in several proteins of the complement system | Back alignment and domain information |
|---|
| >smart00032 CCP Domain abundant in complement control proteins; SUSHI repeat; short complement-like repeat (SCR) | Back alignment and domain information |
|---|
| >PF00084 Sushi: Sushi domain (SCR repeat); InterPro: IPR000436 Sushi domains are also known as Complement control protein (CCP) modules, or short consensus repeats (SCR), exist in a wide variety of complement and adhesion proteins | Back alignment and domain information |
|---|
| >PF14704 DERM: Dermatopontin | Back alignment and domain information |
|---|
| >smart00008 HormR Domain present in hormone receptors | Back alignment and domain information |
|---|
| >PF02793 HRM: Hormone receptor domain; InterPro: IPR001879 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >smart00008 HormR Domain present in hormone receptors | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 222 | ||||
| 2gsx_A | 951 | Complement Receptor Type 2 Length = 951 | 4e-14 | ||
| 2gsx_A | 951 | Complement Receptor Type 2 Length = 951 | 2e-04 | ||
| 2q7z_A | 1931 | Solution Structure Of The 30 Scr Domains Of Human C | 9e-14 | ||
| 1c1z_A | 326 | Crystal Structure Of Human Beta-2-Glycoprotein-I (A | 6e-12 | ||
| 1qub_A | 319 | Crystal Structure Of The Glycosylated Five-domain H | 6e-12 | ||
| 2wii_C | 277 | Complement C3b In Complex With Factor H Domains 1-4 | 1e-10 | ||
| 3gau_A | 1213 | Solution Structure Of Human Complement Factor H In | 1e-10 | ||
| 1haq_A | 1213 | Four Models Of Human Factor H Determined By Solutio | 1e-10 | ||
| 2qfg_A | 312 | Solution Structure Of The N-Terminal Scr-15 FRAGMEN | 2e-10 | ||
| 3o8e_B | 252 | Structure Of Extracelllar Portion Of Cd46 In Comple | 1e-08 | ||
| 1ntl_A | 551 | Model Of Mouse Crry-Ig Determined By Solution Scatt | 5e-08 | ||
| 3iyp_F | 381 | The Interaction Of Decay-Accelerating Factor With E | 1e-07 | ||
| 3iyp_F | 381 | The Interaction Of Decay-Accelerating Factor With E | 2e-06 | ||
| 1ojv_A | 254 | Decay Accelerating Factor (Cd55): The Structure Of | 2e-07 | ||
| 1ojv_A | 254 | Decay Accelerating Factor (Cd55): The Structure Of | 2e-06 | ||
| 2c8i_E | 316 | Complex Of Echovirus Type 12 With Domains 1, 2, 3 A | 2e-07 | ||
| 2c8i_E | 316 | Complex Of Echovirus Type 12 With Domains 1, 2, 3 A | 5e-05 | ||
| 2xrb_A | 290 | Structure Of The N-Terminal Four Domains Of The Com | 2e-07 | ||
| 2ok5_A | 752 | Human Complement Factor B Length = 752 | 3e-07 | ||
| 2ok5_A | 752 | Human Complement Factor B Length = 752 | 6e-05 | ||
| 2xwb_F | 732 | Crystal Structure Of Complement C3b In Complex With | 4e-07 | ||
| 2xwb_F | 732 | Crystal Structure Of Complement C3b In Complex With | 7e-05 | ||
| 3hrz_D | 741 | Cobra Venom Factor (Cvf) In Complex With Human Fact | 4e-07 | ||
| 3hrz_D | 741 | Cobra Venom Factor (Cvf) In Complex With Human Fact | 7e-05 | ||
| 1h04_P | 125 | Human Cd55 Domains 3 & 4 Length = 125 | 5e-07 | ||
| 1ok3_A | 254 | Decay Accelerating Factor (cd55): The Structure Of | 5e-07 | ||
| 1ok3_A | 254 | Decay Accelerating Factor (cd55): The Structure Of | 3e-06 | ||
| 2rlq_A | 129 | Nmr Structure Of Ccp Modules 2-3 Of Complement Fact | 7e-07 | ||
| 2rlq_A | 129 | Nmr Structure Of Ccp Modules 2-3 Of Complement Fact | 6e-06 | ||
| 1h03_P | 125 | Human Cd55 Domains 3 & 4 Length = 125 | 9e-07 | ||
| 1h2p_P | 125 | Human Cd55 Domains 3 & 4 Length = 125 | 9e-07 | ||
| 1upn_E | 129 | Complex Of Echovirus Type 12 With Domains 3 And 4 O | 9e-07 | ||
| 1ntj_A | 320 | Model Of Rat Crry Determined By Solution Scattering | 2e-06 | ||
| 3erb_A | 223 | The Crystal Structure Of C2b, A Fragment Of Complem | 2e-06 | ||
| 1e5g_A | 120 | Solution Structure Of Central Cp Module Pair Of A P | 2e-06 | ||
| 1g40_A | 244 | Crystal Structure Of A Complement Protein That Regu | 3e-06 | ||
| 1m11_R | 243 | Structural Model Of Human Decay-accelerating Factor | 3e-06 | ||
| 1ckl_A | 126 | N-Terminal Two Domains Of Human Cd46 (Membrane Cofa | 2e-05 | ||
| 1gkg_A | 136 | Structure Determination And Rational Mutagenesis Re | 9e-05 | ||
| 1w2r_A | 142 | Solution Structure Of Cr2 Scr 1-2 By X-Ray Scatteri | 9e-05 | ||
| 3oed_C | 135 | The Structure Of The Complex Between Complement Rec | 9e-05 | ||
| 1ghq_B | 134 | Cr2-C3d Complex Structure Length = 134 | 1e-04 | ||
| 2qfh_A | 333 | Solution Structure Of The C-Terminal Scr-1620 FRAGM | 1e-04 | ||
| 1ly2_A | 130 | Crystal Structure Of Unliganded Human Cd21 Scr1-Scr | 2e-04 | ||
| 2a55_A | 133 | Solution Structure Of The Two N-Terminal Ccp Module | 2e-04 | ||
| 1nwv_A | 129 | Solution Structure Of A Functionally Active Compone | 2e-04 | ||
| 2aty_A | 376 | Complement Receptor Chimaeric Conjugate Cr2-Ig Leng | 3e-04 | ||
| 1vvc_A | 118 | C-Terminal Half Of Vaccinia Virus Complement Contro | 3e-04 |
| >pdb|2GSX|A Chain A, Complement Receptor Type 2 Length = 951 | Back alignment and structure |
|
| >pdb|2GSX|A Chain A, Complement Receptor Type 2 Length = 951 | Back alignment and structure |
| >pdb|2Q7Z|A Chain A, Solution Structure Of The 30 Scr Domains Of Human Complement Receptor 1 Length = 1931 | Back alignment and structure |
| >pdb|1C1Z|A Chain A, Crystal Structure Of Human Beta-2-Glycoprotein-I (Apolipoprotein-H) Length = 326 | Back alignment and structure |
| >pdb|1QUB|A Chain A, Crystal Structure Of The Glycosylated Five-domain Human Beta2- Glycoprotein I Purified From Blood Plasma Length = 319 | Back alignment and structure |
| >pdb|2WII|C Chain C, Complement C3b In Complex With Factor H Domains 1-4 Length = 277 | Back alignment and structure |
| >pdb|3GAU|A Chain A, Solution Structure Of Human Complement Factor H In 50 Mm Nacl Buffer Length = 1213 | Back alignment and structure |
| >pdb|1HAQ|A Chain A, Four Models Of Human Factor H Determined By Solution Scattering Curve-Fitting And Homology Modelling Length = 1213 | Back alignment and structure |
| >pdb|2QFG|A Chain A, Solution Structure Of The N-Terminal Scr-15 FRAGMENT OF Complement Factor H Length = 312 | Back alignment and structure |
| >pdb|3O8E|B Chain B, Structure Of Extracelllar Portion Of Cd46 In Complex With Adenovirus Type 11 Knob Length = 252 | Back alignment and structure |
| >pdb|1NTL|A Chain A, Model Of Mouse Crry-Ig Determined By Solution Scattering, Curve Fitting And Homology Modelling Length = 551 | Back alignment and structure |
| >pdb|3IYP|F Chain F, The Interaction Of Decay-Accelerating Factor With Echovirus 7 Length = 381 | Back alignment and structure |
| >pdb|3IYP|F Chain F, The Interaction Of Decay-Accelerating Factor With Echovirus 7 Length = 381 | Back alignment and structure |
| >pdb|1OJV|A Chain A, Decay Accelerating Factor (Cd55): The Structure Of An Intact Human Complement Regulator. Length = 254 | Back alignment and structure |
| >pdb|1OJV|A Chain A, Decay Accelerating Factor (Cd55): The Structure Of An Intact Human Complement Regulator. Length = 254 | Back alignment and structure |
| >pdb|2XRB|A Chain A, Structure Of The N-Terminal Four Domains Of The Complement Regulator Rat Crry Length = 290 | Back alignment and structure |
| >pdb|2OK5|A Chain A, Human Complement Factor B Length = 752 | Back alignment and structure |
| >pdb|2OK5|A Chain A, Human Complement Factor B Length = 752 | Back alignment and structure |
| >pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With Factors B And D Length = 732 | Back alignment and structure |
| >pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With Factors B And D Length = 732 | Back alignment and structure |
| >pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B Length = 741 | Back alignment and structure |
| >pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B Length = 741 | Back alignment and structure |
| >pdb|1H04|P Chain P, Human Cd55 Domains 3 & 4 Length = 125 | Back alignment and structure |
| >pdb|1OK3|A Chain A, Decay Accelerating Factor (cd55): The Structure Of An Intact Human Complement Regulator. Length = 254 | Back alignment and structure |
| >pdb|1OK3|A Chain A, Decay Accelerating Factor (cd55): The Structure Of An Intact Human Complement Regulator. Length = 254 | Back alignment and structure |
| >pdb|2RLQ|A Chain A, Nmr Structure Of Ccp Modules 2-3 Of Complement Factor H Length = 129 | Back alignment and structure |
| >pdb|2RLQ|A Chain A, Nmr Structure Of Ccp Modules 2-3 Of Complement Factor H Length = 129 | Back alignment and structure |
| >pdb|1H03|P Chain P, Human Cd55 Domains 3 & 4 Length = 125 | Back alignment and structure |
| >pdb|1H2P|P Chain P, Human Cd55 Domains 3 & 4 Length = 125 | Back alignment and structure |
| >pdb|1UPN|E Chain E, Complex Of Echovirus Type 12 With Domains 3 And 4 Of Its Receptor Decay Accelerating Factor (Cd55) By Cryo Electron Microscopy At 16 A Length = 129 | Back alignment and structure |
| >pdb|1NTJ|A Chain A, Model Of Rat Crry Determined By Solution Scattering, Curve Fitting And Homology Modelling Length = 320 | Back alignment and structure |
| >pdb|3ERB|A Chain A, The Crystal Structure Of C2b, A Fragment Of Complement Component C2 Produced During C3-Convertase Formation Length = 223 | Back alignment and structure |
| >pdb|1E5G|A Chain A, Solution Structure Of Central Cp Module Pair Of A Pox Virus Complement Inhibitor Length = 120 | Back alignment and structure |
| >pdb|1G40|A Chain A, Crystal Structure Of A Complement Protein That Regulates Both Pathways Of Complement Activation And Binds Heparan Sulfate Proteoglycans Length = 244 | Back alignment and structure |
| >pdb|1M11|R Chain R, Structural Model Of Human Decay-accelerating Factor Bound To Echovirus 7 From Cryo-electron Microscopy Length = 243 | Back alignment and structure |
| >pdb|1CKL|A Chain A, N-Terminal Two Domains Of Human Cd46 (Membrane Cofactor Protein, Mcp) Length = 126 | Back alignment and structure |
| >pdb|1GKG|A Chain A, Structure Determination And Rational Mutagenesis Reveal Binding Surface Of Immune Adherence Receptor, Cr1 (Cd35) Length = 136 | Back alignment and structure |
| >pdb|1W2R|A Chain A, Solution Structure Of Cr2 Scr 1-2 By X-Ray Scattering Length = 142 | Back alignment and structure |
| >pdb|3OED|C Chain C, The Structure Of The Complex Between Complement Receptor Cr2 And Its Ligand Complement Fragment C3d Length = 135 | Back alignment and structure |
| >pdb|1GHQ|B Chain B, Cr2-C3d Complex Structure Length = 134 | Back alignment and structure |
| >pdb|2QFH|A Chain A, Solution Structure Of The C-Terminal Scr-1620 FRAGMENT OF Complement Factor H Length = 333 | Back alignment and structure |
| >pdb|1LY2|A Chain A, Crystal Structure Of Unliganded Human Cd21 Scr1-Scr2 (Complement Receptor Type 2) Length = 130 | Back alignment and structure |
| >pdb|2A55|A Chain A, Solution Structure Of The Two N-Terminal Ccp Modules Of C4b- Binding Protein (C4bp) Alpha-Chain Length = 133 | Back alignment and structure |
| >pdb|1NWV|A Chain A, Solution Structure Of A Functionally Active Component Of Decay Accelerating Factor Length = 129 | Back alignment and structure |
| >pdb|2ATY|A Chain A, Complement Receptor Chimaeric Conjugate Cr2-Ig Length = 376 | Back alignment and structure |
| >pdb|1VVC|A Chain A, C-Terminal Half Of Vaccinia Virus Complement Control Protein, Nmr, Minimized Average Structure Length = 118 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 222 | |||
| 3o8e_B | 252 | Membrane cofactor protein; short consensus repeat, | 1e-41 | |
| 3o8e_B | 252 | Membrane cofactor protein; short consensus repeat, | 7e-28 | |
| 3o8e_B | 252 | Membrane cofactor protein; short consensus repeat, | 1e-27 | |
| 3o8e_B | 252 | Membrane cofactor protein; short consensus repeat, | 6e-05 | |
| 1qub_A | 319 | Protein (human BETA2-glycoprotein I); short consen | 5e-41 | |
| 1qub_A | 319 | Protein (human BETA2-glycoprotein I); short consen | 5e-37 | |
| 1qub_A | 319 | Protein (human BETA2-glycoprotein I); short consen | 2e-31 | |
| 1qub_A | 319 | Protein (human BETA2-glycoprotein I); short consen | 1e-18 | |
| 2wii_C | 277 | H factor 1, complement factor H; immune system, su | 5e-38 | |
| 2wii_C | 277 | H factor 1, complement factor H; immune system, su | 9e-30 | |
| 2wii_C | 277 | H factor 1, complement factor H; immune system, su | 1e-25 | |
| 1ok3_A | 254 | CD55, CR, DAF, complement decay-accelerating facto | 6e-38 | |
| 1ok3_A | 254 | CD55, CR, DAF, complement decay-accelerating facto | 1e-26 | |
| 1ok3_A | 254 | CD55, CR, DAF, complement decay-accelerating facto | 3e-26 | |
| 1ok3_A | 254 | CD55, CR, DAF, complement decay-accelerating facto | 9e-21 | |
| 3hrz_D | 741 | Complement factor B; serine protease, glycosilated | 4e-37 | |
| 3hrz_D | 741 | Complement factor B; serine protease, glycosilated | 5e-31 | |
| 3hrz_D | 741 | Complement factor B; serine protease, glycosilated | 6e-21 | |
| 3hrz_D | 741 | Complement factor B; serine protease, glycosilated | 2e-07 | |
| 3hrz_D | 741 | Complement factor B; serine protease, glycosilated | 3e-05 | |
| 1rid_A | 244 | Complement control protein; regulation, SCR, immun | 5e-37 | |
| 1rid_A | 244 | Complement control protein; regulation, SCR, immun | 1e-30 | |
| 1rid_A | 244 | Complement control protein; regulation, SCR, immun | 8e-06 | |
| 2c8i_E | 316 | CD55, complement decay-accelerating factor; picorn | 7e-37 | |
| 2c8i_E | 316 | CD55, complement decay-accelerating factor; picorn | 2e-29 | |
| 2c8i_E | 316 | CD55, complement decay-accelerating factor; picorn | 1e-26 | |
| 2c8i_E | 316 | CD55, complement decay-accelerating factor; picorn | 4e-26 | |
| 2xrb_A | 290 | Complement regulatory protein CRRY; immune system, | 1e-35 | |
| 2xrb_A | 290 | Complement regulatory protein CRRY; immune system, | 6e-28 | |
| 2xrb_A | 290 | Complement regulatory protein CRRY; immune system, | 3e-25 | |
| 2xrb_A | 290 | Complement regulatory protein CRRY; immune system, | 7e-23 | |
| 2xrb_A | 290 | Complement regulatory protein CRRY; immune system, | 9e-13 | |
| 3iyp_F | 381 | Complement decay-accelerating factor; virus, recep | 6e-35 | |
| 3iyp_F | 381 | Complement decay-accelerating factor; virus, recep | 5e-29 | |
| 3iyp_F | 381 | Complement decay-accelerating factor; virus, recep | 4e-24 | |
| 3iyp_F | 381 | Complement decay-accelerating factor; virus, recep | 2e-19 | |
| 3iyp_F | 381 | Complement decay-accelerating factor; virus, recep | 1e-18 | |
| 3iyp_F | 381 | Complement decay-accelerating factor; virus, recep | 2e-08 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 1e-34 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 7e-32 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 4e-31 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 4e-30 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 5e-30 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 9e-29 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 3e-28 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 6e-25 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 8e-25 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 3e-24 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 5e-24 | |
| 1ntl_A | 551 | CRRY-IG; immunology, complement, glycoprotein, SCR | 2e-34 | |
| 1ntl_A | 551 | CRRY-IG; immunology, complement, glycoprotein, SCR | 1e-31 | |
| 1ntl_A | 551 | CRRY-IG; immunology, complement, glycoprotein, SCR | 9e-26 | |
| 1ntl_A | 551 | CRRY-IG; immunology, complement, glycoprotein, SCR | 4e-25 | |
| 1ntl_A | 551 | CRRY-IG; immunology, complement, glycoprotein, SCR | 2e-19 | |
| 1ntj_A | 320 | Complement receptor related protein; immunology, g | 3e-33 | |
| 1ntj_A | 320 | Complement receptor related protein; immunology, g | 2e-32 | |
| 1ntj_A | 320 | Complement receptor related protein; immunology, g | 6e-25 | |
| 1ntj_A | 320 | Complement receptor related protein; immunology, g | 1e-23 | |
| 1ntj_A | 320 | Complement receptor related protein; immunology, g | 3e-19 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 1e-32 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 6e-28 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 2e-27 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 4e-25 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 7e-25 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 3e-23 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 9e-23 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 1e-22 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 2e-22 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 9e-22 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 5e-21 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 7e-21 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 2e-20 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 3e-18 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 2e-14 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 3e-13 | |
| 3erb_A | 223 | Complement C2; C3/C5 convertase, short consensus r | 2e-30 | |
| 3erb_A | 223 | Complement C2; C3/C5 convertase, short consensus r | 4e-30 | |
| 3erb_A | 223 | Complement C2; C3/C5 convertase, short consensus r | 2e-18 | |
| 3erb_A | 223 | Complement C2; C3/C5 convertase, short consensus r | 5e-04 | |
| 3sw0_X | 188 | H factor 1, complement factor H; innate immune res | 4e-30 | |
| 3sw0_X | 188 | H factor 1, complement factor H; innate immune res | 1e-19 | |
| 3sw0_X | 188 | H factor 1, complement factor H; innate immune res | 3e-18 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 1e-29 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-29 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 3e-29 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-27 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-27 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-27 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 4e-27 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 8e-27 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 1e-26 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-26 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 1e-25 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 1e-25 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-25 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-24 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 5e-23 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 1e-22 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-22 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-22 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 1e-21 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-21 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 4e-21 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 2e-20 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 3e-20 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 7e-19 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 6e-15 | |
| 2uwn_A | 187 | H factor 1, human complement factor H; alternative | 2e-25 | |
| 2uwn_A | 187 | H factor 1, human complement factor H; alternative | 2e-18 | |
| 2uwn_A | 187 | H factor 1, human complement factor H; alternative | 4e-05 | |
| 3gov_A | 155 | MAsp-1; complement, serine protease, beta barrel, | 5e-25 | |
| 3gov_A | 155 | MAsp-1; complement, serine protease, beta barrel, | 2e-21 | |
| 3gov_A | 155 | MAsp-1; complement, serine protease, beta barrel, | 6e-11 | |
| 3gov_A | 155 | MAsp-1; complement, serine protease, beta barrel, | 8e-11 | |
| 1h03_P | 125 | Complement decay-accelerating factor; immune syste | 3e-23 | |
| 1h03_P | 125 | Complement decay-accelerating factor; immune syste | 3e-22 | |
| 1h03_P | 125 | Complement decay-accelerating factor; immune syste | 2e-13 | |
| 1h03_P | 125 | Complement decay-accelerating factor; immune syste | 2e-05 | |
| 1gkn_A | 128 | Complement receptor type 1; module, SCR, structure | 6e-23 | |
| 1gkn_A | 128 | Complement receptor type 1; module, SCR, structure | 2e-19 | |
| 1gkn_A | 128 | Complement receptor type 1; module, SCR, structure | 6e-11 | |
| 1gkn_A | 128 | Complement receptor type 1; module, SCR, structure | 6e-08 | |
| 1ly2_A | 130 | CD21, complement receptor type 2; epstein BARR vir | 2e-22 | |
| 1ly2_A | 130 | CD21, complement receptor type 2; epstein BARR vir | 9e-21 | |
| 1ly2_A | 130 | CD21, complement receptor type 2; epstein BARR vir | 1e-12 | |
| 1ly2_A | 130 | CD21, complement receptor type 2; epstein BARR vir | 2e-07 | |
| 3r62_A | 129 | H factor 1, complement factor H; immunity, repeati | 2e-20 | |
| 3r62_A | 129 | H factor 1, complement factor H; immunity, repeati | 1e-14 | |
| 3r62_A | 129 | H factor 1, complement factor H; immunity, repeati | 4e-08 | |
| 1gkg_A | 136 | Complement receptor type 1; module, SCR, structure | 7e-20 | |
| 1gkg_A | 136 | Complement receptor type 1; module, SCR, structure | 2e-19 | |
| 1gkg_A | 136 | Complement receptor type 1; module, SCR, structure | 1e-09 | |
| 1gkg_A | 136 | Complement receptor type 1; module, SCR, structure | 3e-05 | |
| 2a55_A | 133 | C4B-binding protein; complement, SCR, CCP module, | 1e-19 | |
| 2a55_A | 133 | C4B-binding protein; complement, SCR, CCP module, | 3e-17 | |
| 2a55_A | 133 | C4B-binding protein; complement, SCR, CCP module, | 3e-08 | |
| 2qy0_A | 159 | Complement C1R subcomponent; serine protease, beta | 1e-19 | |
| 2qy0_A | 159 | Complement C1R subcomponent; serine protease, beta | 3e-17 | |
| 2qy0_A | 159 | Complement C1R subcomponent; serine protease, beta | 2e-06 | |
| 3t5o_A | 913 | Complement component C6; macpf, MAC, membrane atta | 3e-17 | |
| 2yby_A | 124 | Complement factor H; immune system, complement reg | 3e-17 | |
| 2yby_A | 124 | Complement factor H; immune system, complement reg | 2e-05 | |
| 2ehf_A | 73 | CUB and sushi domain-containing protein 1; CUB and | 4e-16 | |
| 2ehf_A | 73 | CUB and sushi domain-containing protein 1; CUB and | 5e-13 | |
| 2ehf_A | 73 | CUB and sushi domain-containing protein 1; CUB and | 6e-11 | |
| 2aty_A | 376 | Complement receptor chimeric conjugate CR2-IG; imm | 8e-15 | |
| 2aty_A | 376 | Complement receptor chimeric conjugate CR2-IG; imm | 1e-07 | |
| 2aty_A | 376 | Complement receptor chimeric conjugate CR2-IG; imm | 8e-05 | |
| 2yra_A | 74 | Seizure 6-like protein isoform 3; disulfide bond, | 2e-12 | |
| 2yra_A | 74 | Seizure 6-like protein isoform 3; disulfide bond, | 3e-10 | |
| 2yra_A | 74 | Seizure 6-like protein isoform 3; disulfide bond, | 4e-09 | |
| 1zjk_A | 403 | Mannan-binding lectin serine protease 2; beta barr | 2e-11 | |
| 1zjk_A | 403 | Mannan-binding lectin serine protease 2; beta barr | 1e-10 | |
| 1zjk_A | 403 | Mannan-binding lectin serine protease 2; beta barr | 1e-08 | |
| 3tvj_A | 86 | Mannan-binding lectin serine protease 2 A chain; i | 7e-11 | |
| 3tvj_A | 86 | Mannan-binding lectin serine protease 2 A chain; i | 6e-04 | |
| 1gpz_A | 399 | Complement C1R component; hydrolase, activation, i | 2e-08 | |
| 1gpz_A | 399 | Complement C1R component; hydrolase, activation, i | 3e-08 | |
| 1gpz_A | 399 | Complement C1R component; hydrolase, activation, i | 4e-08 | |
| 4aqb_A | 361 | Mannan-binding lectin serine protease 1; blood clo | 5e-08 | |
| 4aqb_A | 361 | Mannan-binding lectin serine protease 1; blood clo | 7e-06 | |
| 4aqb_A | 361 | Mannan-binding lectin serine protease 1; blood clo | 6e-04 | |
| 1srz_A | 68 | Gamma-aminobutyric acid type B receptor, subunit 1 | 5e-07 |
| >3o8e_B Membrane cofactor protein; short consensus repeat, complement control protein, fiber KN virus-receptor interaction, cell adhesion-immunity complex; HET: NAG; 2.84A {Homo sapiens} PDB: 2o39_C* 1ckl_A* 3inb_C* 3l89_M* Length = 252 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-41
Identities = 51/218 (23%), Positives = 74/218 (33%), Gaps = 28/218 (12%)
Query: 11 GQWSGE-VPTCQQIICPKI-VVENPYLTLVEQNNTYRGHAIFQCSWGYQLKGPPDIVCQK 68
W C + CP I N + F C+ GY L G + C+
Sbjct: 50 HTWLPVSDDACYRETCPYIRDPLNGQAVPANGTYEFGYQMHFICNEGYYLIGEEILYCEL 109
Query: 69 NGS---WSGAIPECNAFFFFFFFFFFNPVHCPVPALPLNGHLIEDPTGGPYRVGAILQFA 125
GS WSG P C V C P NG + + ++
Sbjct: 110 KGSVAIWSGKPPICE------------KVLCTPPPKIKNGKHTFSE-VEVFEYLDAVTYS 156
Query: 126 CN-----DRHHLLGEETIVCTETGRWSRAPPRCKA-RCEYPGEPQNGKIIPLKFFYDPGD 179
C+ D L+GE TI C + WSRA P CK +C +P +I +
Sbjct: 157 CDPAPGPDPFSLIGESTIYCGDNSVWSRAAPECKVVKCRFPVVENGKQISGFGKKFYYKA 216
Query: 180 HIQVTCNDGYVKPLDITPTSGPYCQSDGTWSLDIPHCT 217
+ C+ G+ + + C S+ TW +P C
Sbjct: 217 TVMFECDKGFY----LDGSDTIVCDSNSTWDPPVPKCL 250
|
| >3o8e_B Membrane cofactor protein; short consensus repeat, complement control protein, fiber KN virus-receptor interaction, cell adhesion-immunity complex; HET: NAG; 2.84A {Homo sapiens} PDB: 2o39_C* 1ckl_A* 3inb_C* 3l89_M* Length = 252 | Back alignment and structure |
|---|
| >3o8e_B Membrane cofactor protein; short consensus repeat, complement control protein, fiber KN virus-receptor interaction, cell adhesion-immunity complex; HET: NAG; 2.84A {Homo sapiens} PDB: 2o39_C* 1ckl_A* 3inb_C* 3l89_M* Length = 252 | Back alignment and structure |
|---|
| >3o8e_B Membrane cofactor protein; short consensus repeat, complement control protein, fiber KN virus-receptor interaction, cell adhesion-immunity complex; HET: NAG; 2.84A {Homo sapiens} PDB: 2o39_C* 1ckl_A* 3inb_C* 3l89_M* Length = 252 | Back alignment and structure |
|---|
| >1qub_A Protein (human BETA2-glycoprotein I); short consensus repeat, sushi, complement control protein, N glycosylation, multi-domain, membrane adhesion; HET: NAG MAN; 2.70A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1c1z_A* 1g4f_A 1g4g_A 2kri_A 3op8_A Length = 319 | Back alignment and structure |
|---|
| >1qub_A Protein (human BETA2-glycoprotein I); short consensus repeat, sushi, complement control protein, N glycosylation, multi-domain, membrane adhesion; HET: NAG MAN; 2.70A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1c1z_A* 1g4f_A 1g4g_A 2kri_A 3op8_A Length = 319 | Back alignment and structure |
|---|
| >1qub_A Protein (human BETA2-glycoprotein I); short consensus repeat, sushi, complement control protein, N glycosylation, multi-domain, membrane adhesion; HET: NAG MAN; 2.70A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1c1z_A* 1g4f_A 1g4g_A 2kri_A 3op8_A Length = 319 | Back alignment and structure |
|---|
| >1qub_A Protein (human BETA2-glycoprotein I); short consensus repeat, sushi, complement control protein, N glycosylation, multi-domain, membrane adhesion; HET: NAG MAN; 2.70A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1c1z_A* 1g4f_A 1g4g_A 2kri_A 3op8_A Length = 319 | Back alignment and structure |
|---|
| >2wii_C H factor 1, complement factor H; immune system, sushi, secreted, polymorphism, glycoprotein, complement system, complement pathway, immune response; HET: NAG BMA; 2.70A {Homo sapiens} PDB: 2rlp_A 2rlq_A Length = 277 | Back alignment and structure |
|---|
| >2wii_C H factor 1, complement factor H; immune system, sushi, secreted, polymorphism, glycoprotein, complement system, complement pathway, immune response; HET: NAG BMA; 2.70A {Homo sapiens} PDB: 2rlp_A 2rlq_A Length = 277 | Back alignment and structure |
|---|
| >2wii_C H factor 1, complement factor H; immune system, sushi, secreted, polymorphism, glycoprotein, complement system, complement pathway, immune response; HET: NAG BMA; 2.70A {Homo sapiens} PDB: 2rlp_A 2rlq_A Length = 277 | Back alignment and structure |
|---|
| >1ok3_A CD55, CR, DAF, complement decay-accelerating factor; regulator of complement pathway, regulator of complement; 2.2A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1ojw_A 1ojy_A 1ok1_A 1ok2_A 1ojv_A 1ok9_A 1m11_R 1nwv_A 2qzh_A 2qzf_A Length = 254 | Back alignment and structure |
|---|
| >1ok3_A CD55, CR, DAF, complement decay-accelerating factor; regulator of complement pathway, regulator of complement; 2.2A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1ojw_A 1ojy_A 1ok1_A 1ok2_A 1ojv_A 1ok9_A 1m11_R 1nwv_A 2qzh_A 2qzf_A Length = 254 | Back alignment and structure |
|---|
| >1ok3_A CD55, CR, DAF, complement decay-accelerating factor; regulator of complement pathway, regulator of complement; 2.2A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1ojw_A 1ojy_A 1ok1_A 1ok2_A 1ojv_A 1ok9_A 1m11_R 1nwv_A 2qzh_A 2qzf_A Length = 254 | Back alignment and structure |
|---|
| >1ok3_A CD55, CR, DAF, complement decay-accelerating factor; regulator of complement pathway, regulator of complement; 2.2A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1ojw_A 1ojy_A 1ok1_A 1ok2_A 1ojv_A 1ok9_A 1m11_R 1nwv_A 2qzh_A 2qzf_A Length = 254 | Back alignment and structure |
|---|
| >3hrz_D Complement factor B; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Homo sapiens} PDB: 2xwj_I* 3hs0_D* 2ok5_A* 2xwb_F* Length = 741 | Back alignment and structure |
|---|
| >3hrz_D Complement factor B; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Homo sapiens} PDB: 2xwj_I* 3hs0_D* 2ok5_A* 2xwb_F* Length = 741 | Back alignment and structure |
|---|
| >3hrz_D Complement factor B; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Homo sapiens} PDB: 2xwj_I* 3hs0_D* 2ok5_A* 2xwb_F* Length = 741 | Back alignment and structure |
|---|
| >3hrz_D Complement factor B; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Homo sapiens} PDB: 2xwj_I* 3hs0_D* 2ok5_A* 2xwb_F* Length = 741 | Back alignment and structure |
|---|
| >3hrz_D Complement factor B; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Homo sapiens} PDB: 2xwj_I* 3hs0_D* 2ok5_A* 2xwb_F* Length = 741 | Back alignment and structure |
|---|
| >1rid_A Complement control protein; regulation, SCR, immune system; HET: IDS SGN; 2.10A {Vaccinia virus} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1g44_A 1g40_A* 1y8e_A* 1e5g_A 1vvc_A 1vvd_A 1vve_A Length = 244 | Back alignment and structure |
|---|
| >1rid_A Complement control protein; regulation, SCR, immune system; HET: IDS SGN; 2.10A {Vaccinia virus} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1g44_A 1g40_A* 1y8e_A* 1e5g_A 1vvc_A 1vvd_A 1vve_A Length = 244 | Back alignment and structure |
|---|
| >1rid_A Complement control protein; regulation, SCR, immune system; HET: IDS SGN; 2.10A {Vaccinia virus} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1g44_A 1g40_A* 1y8e_A* 1e5g_A 1vvc_A 1vvd_A 1vve_A Length = 244 | Back alignment and structure |
|---|
| >2xrb_A Complement regulatory protein CRRY; immune system, immunology; 2.50A {Rattus norvegicus} PDB: 2xrd_A Length = 290 | Back alignment and structure |
|---|
| >2xrb_A Complement regulatory protein CRRY; immune system, immunology; 2.50A {Rattus norvegicus} PDB: 2xrd_A Length = 290 | Back alignment and structure |
|---|
| >2xrb_A Complement regulatory protein CRRY; immune system, immunology; 2.50A {Rattus norvegicus} PDB: 2xrd_A Length = 290 | Back alignment and structure |
|---|
| >2xrb_A Complement regulatory protein CRRY; immune system, immunology; 2.50A {Rattus norvegicus} PDB: 2xrd_A Length = 290 | Back alignment and structure |
|---|
| >2xrb_A Complement regulatory protein CRRY; immune system, immunology; 2.50A {Rattus norvegicus} PDB: 2xrd_A Length = 290 | Back alignment and structure |
|---|
| >3iyp_F Complement decay-accelerating factor; virus, receptor, complex, echovirus, DAF, icosahedral virus; HET: DAO; 7.20A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
| >3iyp_F Complement decay-accelerating factor; virus, receptor, complex, echovirus, DAF, icosahedral virus; HET: DAO; 7.20A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
| >3iyp_F Complement decay-accelerating factor; virus, receptor, complex, echovirus, DAF, icosahedral virus; HET: DAO; 7.20A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
| >3iyp_F Complement decay-accelerating factor; virus, receptor, complex, echovirus, DAF, icosahedral virus; HET: DAO; 7.20A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
| >3iyp_F Complement decay-accelerating factor; virus, receptor, complex, echovirus, DAF, icosahedral virus; HET: DAO; 7.20A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
| >3iyp_F Complement decay-accelerating factor; virus, receptor, complex, echovirus, DAF, icosahedral virus; HET: DAO; 7.20A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} Length = 951 | Back alignment and structure |
|---|
| >1ntl_A CRRY-IG; immunology, complement, glycoprotein, SCR, CCP, immune system; NMR {Mus musculus} Length = 551 | Back alignment and structure |
|---|
| >1ntl_A CRRY-IG; immunology, complement, glycoprotein, SCR, CCP, immune system; NMR {Mus musculus} Length = 551 | Back alignment and structure |
|---|
| >1ntl_A CRRY-IG; immunology, complement, glycoprotein, SCR, CCP, immune system; NMR {Mus musculus} Length = 551 | Back alignment and structure |
|---|
| >1ntl_A CRRY-IG; immunology, complement, glycoprotein, SCR, CCP, immune system; NMR {Mus musculus} Length = 551 | Back alignment and structure |
|---|
| >1ntl_A CRRY-IG; immunology, complement, glycoprotein, SCR, CCP, immune system; NMR {Mus musculus} Length = 551 | Back alignment and structure |
|---|
| >1ntj_A Complement receptor related protein; immunology, glycoprotein, SCR, CCP, immune system; NMR {Rattus norvegicus} Length = 320 | Back alignment and structure |
|---|
| >1ntj_A Complement receptor related protein; immunology, glycoprotein, SCR, CCP, immune system; NMR {Rattus norvegicus} Length = 320 | Back alignment and structure |
|---|
| >1ntj_A Complement receptor related protein; immunology, glycoprotein, SCR, CCP, immune system; NMR {Rattus norvegicus} Length = 320 | Back alignment and structure |
|---|
| >1ntj_A Complement receptor related protein; immunology, glycoprotein, SCR, CCP, immune system; NMR {Rattus norvegicus} Length = 320 | Back alignment and structure |
|---|
| >1ntj_A Complement receptor related protein; immunology, glycoprotein, SCR, CCP, immune system; NMR {Rattus norvegicus} Length = 320 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A Length = 1213 | Back alignment and structure |
|---|
| >3erb_A Complement C2; C3/C5 convertase, short consensus repeat(SCR), sushi domain, human complement system, complement second component C2; 1.80A {Homo sapiens} Length = 223 | Back alignment and structure |
|---|
| >3erb_A Complement C2; C3/C5 convertase, short consensus repeat(SCR), sushi domain, human complement system, complement second component C2; 1.80A {Homo sapiens} Length = 223 | Back alignment and structure |
|---|
| >3erb_A Complement C2; C3/C5 convertase, short consensus repeat(SCR), sushi domain, human complement system, complement second component C2; 1.80A {Homo sapiens} Length = 223 | Back alignment and structure |
|---|
| >3erb_A Complement C2; C3/C5 convertase, short consensus repeat(SCR), sushi domain, human complement system, complement second component C2; 1.80A {Homo sapiens} Length = 223 | Back alignment and structure |
|---|
| >3sw0_X H factor 1, complement factor H; innate immune response, sushi domains, cofactor in the inact of C3B, C3B, human plasma, immune system; 1.80A {Homo sapiens} Length = 188 | Back alignment and structure |
|---|
| >3sw0_X H factor 1, complement factor H; innate immune response, sushi domains, cofactor in the inact of C3B, C3B, human plasma, immune system; 1.80A {Homo sapiens} Length = 188 | Back alignment and structure |
|---|
| >3sw0_X H factor 1, complement factor H; innate immune response, sushi domains, cofactor in the inact of C3B, C3B, human plasma, immune system; 1.80A {Homo sapiens} Length = 188 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} Length = 1931 | Back alignment and structure |
|---|
| >2uwn_A H factor 1, human complement factor H; alternative splicing, sucrose octasulphate, AGE-related macular degeneration, complement alternate pathway; HET: SCR; 2.35A {Homo sapiens} PDB: 2v8e_A* 2ic4_A 2w80_A 2w81_A 2jgw_A 2jgx_A Length = 187 | Back alignment and structure |
|---|
| >2uwn_A H factor 1, human complement factor H; alternative splicing, sucrose octasulphate, AGE-related macular degeneration, complement alternate pathway; HET: SCR; 2.35A {Homo sapiens} PDB: 2v8e_A* 2ic4_A 2w80_A 2w81_A 2jgw_A 2jgx_A Length = 187 | Back alignment and structure |
|---|
| >2uwn_A H factor 1, human complement factor H; alternative splicing, sucrose octasulphate, AGE-related macular degeneration, complement alternate pathway; HET: SCR; 2.35A {Homo sapiens} PDB: 2v8e_A* 2ic4_A 2w80_A 2w81_A 2jgw_A 2jgx_A Length = 187 | Back alignment and structure |
|---|
| >3gov_A MAsp-1; complement, serine protease, beta barrel, hydrolase, hydroxy immune response, innate immunity, sushi, coagulation, compl pathway; 2.55A {Homo sapiens} PDB: 4djz_A Length = 155 | Back alignment and structure |
|---|
| >3gov_A MAsp-1; complement, serine protease, beta barrel, hydrolase, hydroxy immune response, innate immunity, sushi, coagulation, compl pathway; 2.55A {Homo sapiens} PDB: 4djz_A Length = 155 | Back alignment and structure |
|---|
| >3gov_A MAsp-1; complement, serine protease, beta barrel, hydrolase, hydroxy immune response, innate immunity, sushi, coagulation, compl pathway; 2.55A {Homo sapiens} PDB: 4djz_A Length = 155 | Back alignment and structure |
|---|
| >3gov_A MAsp-1; complement, serine protease, beta barrel, hydrolase, hydroxy immune response, innate immunity, sushi, coagulation, compl pathway; 2.55A {Homo sapiens} PDB: 4djz_A Length = 155 | Back alignment and structure |
|---|
| >1h03_P Complement decay-accelerating factor; immune system protein, enteroviral receptor, bacterial receptor, ligand for CD97, complement pathway; 1.7A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1h2q_P 1uot_P 1upn_E 1h2p_P 1h04_P 2qzd_A Length = 125 | Back alignment and structure |
|---|
| >1h03_P Complement decay-accelerating factor; immune system protein, enteroviral receptor, bacterial receptor, ligand for CD97, complement pathway; 1.7A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1h2q_P 1uot_P 1upn_E 1h2p_P 1h04_P 2qzd_A Length = 125 | Back alignment and structure |
|---|
| >1h03_P Complement decay-accelerating factor; immune system protein, enteroviral receptor, bacterial receptor, ligand for CD97, complement pathway; 1.7A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1h2q_P 1uot_P 1upn_E 1h2p_P 1h04_P 2qzd_A Length = 125 | Back alignment and structure |
|---|
| >1h03_P Complement decay-accelerating factor; immune system protein, enteroviral receptor, bacterial receptor, ligand for CD97, complement pathway; 1.7A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1h2q_P 1uot_P 1upn_E 1h2p_P 1h04_P 2qzd_A Length = 125 | Back alignment and structure |
|---|
| >1gkn_A Complement receptor type 1; module, SCR, structure; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 Length = 128 | Back alignment and structure |
|---|
| >1gkn_A Complement receptor type 1; module, SCR, structure; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 Length = 128 | Back alignment and structure |
|---|
| >1gkn_A Complement receptor type 1; module, SCR, structure; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 Length = 128 | Back alignment and structure |
|---|
| >1gkn_A Complement receptor type 1; module, SCR, structure; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 Length = 128 | Back alignment and structure |
|---|
| >1ly2_A CD21, complement receptor type 2; epstein BARR virus, regulator of comple activation, short consensus repeat, viral receptor; HET: NAG; 1.80A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1w2r_A 1w2s_B 1ghq_B* 3oed_C Length = 130 | Back alignment and structure |
|---|
| >1ly2_A CD21, complement receptor type 2; epstein BARR virus, regulator of comple activation, short consensus repeat, viral receptor; HET: NAG; 1.80A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1w2r_A 1w2s_B 1ghq_B* 3oed_C Length = 130 | Back alignment and structure |
|---|
| >1ly2_A CD21, complement receptor type 2; epstein BARR virus, regulator of comple activation, short consensus repeat, viral receptor; HET: NAG; 1.80A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1w2r_A 1w2s_B 1ghq_B* 3oed_C Length = 130 | Back alignment and structure |
|---|
| >1ly2_A CD21, complement receptor type 2; epstein BARR virus, regulator of comple activation, short consensus repeat, viral receptor; HET: NAG; 1.80A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1w2r_A 1w2s_B 1ghq_B* 3oed_C Length = 130 | Back alignment and structure |
|---|
| >3r62_A H factor 1, complement factor H; immunity, repeating sushi domain, regulator of C activation, C3D, immune system; 1.52A {Homo sapiens} PDB: 2bzm_A 3oxu_D 3rj3_D 2g7i_A 3kxv_A 3kzj_A 2xqw_C Length = 129 | Back alignment and structure |
|---|
| >3r62_A H factor 1, complement factor H; immunity, repeating sushi domain, regulator of C activation, C3D, immune system; 1.52A {Homo sapiens} PDB: 2bzm_A 3oxu_D 3rj3_D 2g7i_A 3kxv_A 3kzj_A 2xqw_C Length = 129 | Back alignment and structure |
|---|
| >3r62_A H factor 1, complement factor H; immunity, repeating sushi domain, regulator of C activation, C3D, immune system; 1.52A {Homo sapiens} PDB: 2bzm_A 3oxu_D 3rj3_D 2g7i_A 3kxv_A 3kzj_A 2xqw_C Length = 129 | Back alignment and structure |
|---|
| >1gkg_A Complement receptor type 1; module, SCR, structure, sushi; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1ppq_A Length = 136 | Back alignment and structure |
|---|
| >1gkg_A Complement receptor type 1; module, SCR, structure, sushi; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1ppq_A Length = 136 | Back alignment and structure |
|---|
| >1gkg_A Complement receptor type 1; module, SCR, structure, sushi; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1ppq_A Length = 136 | Back alignment and structure |
|---|
| >1gkg_A Complement receptor type 1; module, SCR, structure, sushi; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1ppq_A Length = 136 | Back alignment and structure |
|---|
| >2a55_A C4B-binding protein; complement, SCR, CCP module, immune system; NMR {Homo sapiens} Length = 133 | Back alignment and structure |
|---|
| >2a55_A C4B-binding protein; complement, SCR, CCP module, immune system; NMR {Homo sapiens} Length = 133 | Back alignment and structure |
|---|
| >2a55_A C4B-binding protein; complement, SCR, CCP module, immune system; NMR {Homo sapiens} Length = 133 | Back alignment and structure |
|---|
| >2qy0_A Complement C1R subcomponent; serine protease, beta barrel, complement pathway like domain, glycoprotein, hydrolase, hydroxylation, immune response; 2.60A {Homo sapiens} Length = 159 | Back alignment and structure |
|---|
| >2qy0_A Complement C1R subcomponent; serine protease, beta barrel, complement pathway like domain, glycoprotein, hydrolase, hydroxylation, immune response; 2.60A {Homo sapiens} Length = 159 | Back alignment and structure |
|---|
| >2qy0_A Complement C1R subcomponent; serine protease, beta barrel, complement pathway like domain, glycoprotein, hydrolase, hydroxylation, immune response; 2.60A {Homo sapiens} Length = 159 | Back alignment and structure |
|---|
| >3t5o_A Complement component C6; macpf, MAC, membrane attack complex, innate IMMU system, blood, membrane, cytolysin, immune SYST; HET: NAG FUL FUC BGC MAN; 2.87A {Homo sapiens} PDB: 4a5w_B* 4e0s_B* Length = 913 | Back alignment and structure |
|---|
| >2yby_A Complement factor H; immune system, complement regulation, innate immunity, infec; 1.58A {Mus musculus} Length = 124 | Back alignment and structure |
|---|
| >2yby_A Complement factor H; immune system, complement regulation, innate immunity, infec; 1.58A {Mus musculus} Length = 124 | Back alignment and structure |
|---|
| >2ehf_A CUB and sushi domain-containing protein 1; CUB and sushi multiple domains protein 1, CSMD1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 73 | Back alignment and structure |
|---|
| >2ehf_A CUB and sushi domain-containing protein 1; CUB and sushi multiple domains protein 1, CSMD1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 73 | Back alignment and structure |
|---|
| >2ehf_A CUB and sushi domain-containing protein 1; CUB and sushi multiple domains protein 1, CSMD1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 73 | Back alignment and structure |
|---|
| >2aty_A Complement receptor chimeric conjugate CR2-IG; immunoglobulin fold, antibody, immune system; NMR {Homo sapiens} Length = 376 | Back alignment and structure |
|---|
| >2aty_A Complement receptor chimeric conjugate CR2-IG; immunoglobulin fold, antibody, immune system; NMR {Homo sapiens} Length = 376 | Back alignment and structure |
|---|
| >2aty_A Complement receptor chimeric conjugate CR2-IG; immunoglobulin fold, antibody, immune system; NMR {Homo sapiens} Length = 376 | Back alignment and structure |
|---|
| >2yra_A Seizure 6-like protein isoform 3; disulfide bond, sushi domain, SCR, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 74 | Back alignment and structure |
|---|
| >2yra_A Seizure 6-like protein isoform 3; disulfide bond, sushi domain, SCR, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 74 | Back alignment and structure |
|---|
| >2yra_A Seizure 6-like protein isoform 3; disulfide bond, sushi domain, SCR, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 74 | Back alignment and structure |
|---|
| >1zjk_A Mannan-binding lectin serine protease 2; beta barrel, modular protein, hydrolase; 2.18A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 PDB: 1q3x_A Length = 403 | Back alignment and structure |
|---|
| >1zjk_A Mannan-binding lectin serine protease 2; beta barrel, modular protein, hydrolase; 2.18A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 PDB: 1q3x_A Length = 403 | Back alignment and structure |
|---|
| >1zjk_A Mannan-binding lectin serine protease 2; beta barrel, modular protein, hydrolase; 2.18A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 PDB: 1q3x_A Length = 403 | Back alignment and structure |
|---|
| >3tvj_A Mannan-binding lectin serine protease 2 A chain; in vitro evolution, specific inhibitor, allostery, hydrolase; 1.28A {Homo sapiens} Length = 86 | Back alignment and structure |
|---|
| >3tvj_A Mannan-binding lectin serine protease 2 A chain; in vitro evolution, specific inhibitor, allostery, hydrolase; 1.28A {Homo sapiens} Length = 86 | Back alignment and structure |
|---|
| >1gpz_A Complement C1R component; hydrolase, activation, innate immunity, modular structure, serine protease; HET: NAG FUC MAN; 2.9A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 Length = 399 | Back alignment and structure |
|---|
| >1gpz_A Complement C1R component; hydrolase, activation, innate immunity, modular structure, serine protease; HET: NAG FUC MAN; 2.9A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 Length = 399 | Back alignment and structure |
|---|
| >1gpz_A Complement C1R component; hydrolase, activation, innate immunity, modular structure, serine protease; HET: NAG FUC MAN; 2.9A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 Length = 399 | Back alignment and structure |
|---|
| >4aqb_A Mannan-binding lectin serine protease 1; blood clotting, mannan-binding protein, complement, ficolins complement pathway, mannose- binding lectin; HET: NAG BMA MAN; 4.20A {Homo sapiens} Length = 361 | Back alignment and structure |
|---|
| >4aqb_A Mannan-binding lectin serine protease 1; blood clotting, mannan-binding protein, complement, ficolins complement pathway, mannose- binding lectin; HET: NAG BMA MAN; 4.20A {Homo sapiens} Length = 361 | Back alignment and structure |
|---|
| >4aqb_A Mannan-binding lectin serine protease 1; blood clotting, mannan-binding protein, complement, ficolins complement pathway, mannose- binding lectin; HET: NAG BMA MAN; 4.20A {Homo sapiens} Length = 361 | Back alignment and structure |
|---|
| >1srz_A Gamma-aminobutyric acid type B receptor, subunit 1; GABA(B) receptor, CIS-trans isomerization, CCP module, sushi domain; NMR {Rattus norvegicus} SCOP: g.18.1.1 PDB: 1ss2_A Length = 68 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 222 | |||
| 3o8e_B | 252 | Membrane cofactor protein; short consensus repeat, | 100.0 | |
| 1qub_A | 319 | Protein (human BETA2-glycoprotein I); short consen | 100.0 | |
| 1ok3_A | 254 | CD55, CR, DAF, complement decay-accelerating facto | 100.0 | |
| 2xrb_A | 290 | Complement regulatory protein CRRY; immune system, | 100.0 | |
| 3iyp_F | 381 | Complement decay-accelerating factor; virus, recep | 100.0 | |
| 2wii_C | 277 | H factor 1, complement factor H; immune system, su | 100.0 | |
| 1ntj_A | 320 | Complement receptor related protein; immunology, g | 100.0 | |
| 2c8i_E | 316 | CD55, complement decay-accelerating factor; picorn | 100.0 | |
| 1rid_A | 244 | Complement control protein; regulation, SCR, immun | 100.0 | |
| 1ntj_A | 320 | Complement receptor related protein; immunology, g | 100.0 | |
| 1ntl_A | 551 | CRRY-IG; immunology, complement, glycoprotein, SCR | 100.0 | |
| 1qub_A | 319 | Protein (human BETA2-glycoprotein I); short consen | 100.0 | |
| 2c8i_E | 316 | CD55, complement decay-accelerating factor; picorn | 100.0 | |
| 1ntl_A | 551 | CRRY-IG; immunology, complement, glycoprotein, SCR | 100.0 | |
| 3erb_A | 223 | Complement C2; C3/C5 convertase, short consensus r | 100.0 | |
| 3o8e_B | 252 | Membrane cofactor protein; short consensus repeat, | 100.0 | |
| 2wii_C | 277 | H factor 1, complement factor H; immune system, su | 100.0 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 100.0 | |
| 2gsx_A | 951 | Complement receptor type 2; SCR domain, CCP domain | 100.0 | |
| 3sw0_X | 188 | H factor 1, complement factor H; innate immune res | 100.0 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 100.0 | |
| 1rid_A | 244 | Complement control protein; regulation, SCR, immun | 100.0 | |
| 1ok3_A | 254 | CD55, CR, DAF, complement decay-accelerating facto | 100.0 | |
| 1haq_A | 1213 | Complement factor H; immunology, glycoprotein, com | 100.0 | |
| 2xrb_A | 290 | Complement regulatory protein CRRY; immune system, | 99.98 | |
| 2uwn_A | 187 | H factor 1, human complement factor H; alternative | 99.97 | |
| 3hrz_D | 741 | Complement factor B; serine protease, glycosilated | 99.97 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 99.97 | |
| 3iyp_F | 381 | Complement decay-accelerating factor; virus, recep | 99.97 | |
| 2q7z_A | 1931 | Complement receptor type 1; SCR domain, blood grou | 99.97 | |
| 3erb_A | 223 | Complement C2; C3/C5 convertase, short consensus r | 99.96 | |
| 3gov_A | 155 | MAsp-1; complement, serine protease, beta barrel, | 99.96 | |
| 2qy0_A | 159 | Complement C1R subcomponent; serine protease, beta | 99.94 | |
| 1gkn_A | 128 | Complement receptor type 1; module, SCR, structure | 99.93 | |
| 1gkg_A | 136 | Complement receptor type 1; module, SCR, structure | 99.93 | |
| 3hrz_D | 741 | Complement factor B; serine protease, glycosilated | 99.92 | |
| 3t5o_A | 913 | Complement component C6; macpf, MAC, membrane atta | 99.92 | |
| 1ly2_A | 130 | CD21, complement receptor type 2; epstein BARR vir | 99.92 | |
| 1gkn_A | 128 | Complement receptor type 1; module, SCR, structure | 99.92 | |
| 2uwn_A | 187 | H factor 1, human complement factor H; alternative | 99.92 | |
| 1h03_P | 125 | Complement decay-accelerating factor; immune syste | 99.92 | |
| 1h03_P | 125 | Complement decay-accelerating factor; immune syste | 99.92 | |
| 1gkg_A | 136 | Complement receptor type 1; module, SCR, structure | 99.91 | |
| 1ly2_A | 130 | CD21, complement receptor type 2; epstein BARR vir | 99.91 | |
| 3gov_A | 155 | MAsp-1; complement, serine protease, beta barrel, | 99.91 | |
| 3t5o_A | 913 | Complement component C6; macpf, MAC, membrane atta | 99.91 | |
| 2a55_A | 133 | C4B-binding protein; complement, SCR, CCP module, | 99.9 | |
| 2qy0_A | 159 | Complement C1R subcomponent; serine protease, beta | 99.9 | |
| 2aty_A | 376 | Complement receptor chimeric conjugate CR2-IG; imm | 99.9 | |
| 3sw0_X | 188 | H factor 1, complement factor H; innate immune res | 99.9 | |
| 2a55_A | 133 | C4B-binding protein; complement, SCR, CCP module, | 99.9 | |
| 1zjk_A | 403 | Mannan-binding lectin serine protease 2; beta barr | 99.88 | |
| 3r62_A | 129 | H factor 1, complement factor H; immunity, repeati | 99.88 | |
| 3r62_A | 129 | H factor 1, complement factor H; immunity, repeati | 99.86 | |
| 2aty_A | 376 | Complement receptor chimeric conjugate CR2-IG; imm | 99.86 | |
| 2yby_A | 124 | Complement factor H; immune system, complement reg | 99.85 | |
| 2yby_A | 124 | Complement factor H; immune system, complement reg | 99.83 | |
| 4ayi_A | 125 | H factor 1, complement factor H; immune system, an | 99.83 | |
| 4ayi_A | 125 | H factor 1, complement factor H; immune system, an | 99.8 | |
| 1zjk_A | 403 | Mannan-binding lectin serine protease 2; beta barr | 99.78 | |
| 1gpz_A | 399 | Complement C1R component; hydrolase, activation, i | 99.75 | |
| 2b5i_D | 217 | Interleukin-2 receptor alpha chain; four-helix bun | 99.7 | |
| 2ehf_A | 73 | CUB and sushi domain-containing protein 1; CUB and | 99.66 | |
| 2ehf_A | 73 | CUB and sushi domain-containing protein 1; CUB and | 99.66 | |
| 1gpz_A | 399 | Complement C1R component; hydrolase, activation, i | 99.65 | |
| 2b5i_D | 217 | Interleukin-2 receptor alpha chain; four-helix bun | 99.63 | |
| 2yra_A | 74 | Seizure 6-like protein isoform 3; disulfide bond, | 99.59 | |
| 2yra_A | 74 | Seizure 6-like protein isoform 3; disulfide bond, | 99.52 | |
| 3tvj_A | 86 | Mannan-binding lectin serine protease 2 A chain; i | 99.49 | |
| 3tvj_A | 86 | Mannan-binding lectin serine protease 2 A chain; i | 99.45 | |
| 1srz_A | 68 | Gamma-aminobutyric acid type B receptor, subunit 1 | 99.45 | |
| 1srz_A | 68 | Gamma-aminobutyric acid type B receptor, subunit 1 | 99.42 | |
| 4aqb_A | 361 | Mannan-binding lectin serine protease 1; blood clo | 99.11 | |
| 4aqb_A | 361 | Mannan-binding lectin serine protease 1; blood clo | 99.08 | |
| 2psm_F | 78 | Interleukin-15 receptor alpha chain; cytokine, gly | 98.47 | |
| 2psm_F | 78 | Interleukin-15 receptor alpha chain; cytokine, gly | 98.47 | |
| 1elv_A | 333 | Complement C1S component; trypsin-like serin prote | 98.09 | |
| 2z3q_B | 107 | Interleukin-15 receptor alpha chain; protein-prote | 98.03 | |
| 2z3q_B | 107 | Interleukin-15 receptor alpha chain; protein-prote | 98.01 | |
| 1elv_A | 333 | Complement C1S component; trypsin-like serin prote | 97.79 | |
| 4f4o_C | 347 | Haptoglobin; globin fold, serine protease fold, co | 97.58 | |
| 4f4o_C | 347 | Haptoglobin; globin fold, serine protease fold, co | 97.27 | |
| 1md8_A | 329 | C1R complement serine protease; innate immunity, a | 97.19 | |
| 1md8_A | 329 | C1R complement serine protease; innate immunity, a | 96.08 |
| >3o8e_B Membrane cofactor protein; short consensus repeat, complement control protein, fiber KN virus-receptor interaction, cell adhesion-immunity complex; HET: NAG; 2.84A {Homo sapiens} PDB: 2o39_C* 1ckl_A* 3inb_C* 3l89_M* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=274.10 Aligned_cols=199 Identities=26% Similarity=0.528 Sum_probs=179.9
Q ss_pred CceEeccCCccCC-CCCeeEEeeCCCCcc-CCCeEEeccCCcccccEEEEEcCCCCeEeCCCceEeCCCC---eeeCCCC
Q psy14531 3 HPVFRVSQGQWSG-EVPTCQQIICPKIVV-ENPYLTLVEQNNTYRGHAIFQCSWGYQLKGPPDIVCQKNG---SWSGAIP 77 (222)
Q Consensus 3 ~~~~c~~~g~Ws~-~~p~C~~~~C~~p~~-~ng~~~~~~~~~~~g~~~~~~C~~gy~l~G~~~~~C~~~g---~W~~~~p 77 (222)
.+++|+.+|+|+. ..|.|+++.|+.|+. +||.+......|.+|++|+|+|+.||.|.|+..++|+.+| +|+.+.|
T Consensus 42 ~~~~C~~~g~Ws~~~~p~C~~~~C~~p~~~~nG~~~~~~~~~~~g~~~~~~C~~Gy~l~G~~~~~C~~~G~~~~Ws~~~P 121 (252)
T 3o8e_B 42 THTICDRNHTWLPVSDDACYRETCPYIRDPLNGQAVPANGTYEFGYQMHFICNEGYYLIGEEILYCELKGSVAIWSGKPP 121 (252)
T ss_dssp CEEEBCTTSSBCCCCSTTEEECBCCCCCCCTTEEEEETTSSSBTTCEEEEEECTTEEEESCSEEEEEESSSCEEESSCCC
T ss_pred CeEEECCCCcCCCCCCCceeeeECcCCCCCCCcEEeecCCCccCCCEEEEECCCCCeECCCCEEEEeCCCCCCeeCCCCC
Confidence 5799999999998 589999999999887 9999987767799999999999999999999999999888 8999999
Q ss_pred ceeccceeeeecccccccCCCCCCCCCceEEeCCCCCCcCCCCEEEEEcCC-----CCEEcCCCeEEeCcCCeeeCCCCc
Q psy14531 78 ECNAFFFFFFFFFFNPVHCPVPALPLNGHLIEDPTGGPYRVGAILQFACND-----RHHLLGEETIVCTETGRWSRAPPR 152 (222)
Q Consensus 78 ~C~~~~~~~~~~~~~~~~C~~p~~~~~g~~~~~~~~~~~~~g~~~~~~C~~-----gy~~~g~~~~~C~~~g~Ws~~~p~ 152 (222)
.|+. +.|+.|+.+.||.+... ....|.+|++|+|+|+. ||.|.|...++|+++|+|++..|.
T Consensus 122 ~C~~------------~~C~~p~~~~nG~~~~~-~~~~~~~g~~v~y~C~~g~~~~gy~l~G~~~~~C~~~G~Ws~~~P~ 188 (252)
T 3o8e_B 122 ICEK------------VLCTPPPKIKNGKHTFS-EVEVFEYLDAVTYSCDPAPGPDPFSLIGESTIYCGDNSVWSRAAPE 188 (252)
T ss_dssp EEEE------------CEECCCCCCTTEEESST-TCCCEETTCEEEEEECCCSSSSCCEEESCSEEEBCTTSSBSSCCCE
T ss_pred eEee------------eEcCCCCCCCCCcEecc-CCceecCCCEEEEEeCCCCCCCCeEEeCCCceEECCCCeECCCCCE
Confidence 9999 89999999999988643 35678999999999998 899999999999999999999999
Q ss_pred ee-ecCCCCCCCCCeEEec-CccccCCCCeEEEEcCCCCeeccCCCCCCcceeCCCCcccCCCCceeeC
Q psy14531 153 CK-ARCEYPGEPQNGKIIP-LKFFYDPGDHIQVTCNDGYVKPLDITPTSGPYCQSDGTWSLDIPHCTNY 219 (222)
Q Consensus 153 C~-~~C~~p~~~~~g~~~~-~~~~~~~g~~v~y~C~~gy~~~~~~~~~~~~~C~~~G~W~~~~p~C~~~ 219 (222)
|+ +.|..| .+.||.+.. .+..|.+|+.|+|.|++||.+.|+ ..++|+.+|+|++++|+|+++
T Consensus 189 C~~v~C~~P-~~~ng~~~~~~~~~~~~g~~v~f~C~~Gy~l~G~----~~~~C~~~g~Ws~~~P~C~~v 252 (252)
T 3o8e_B 189 CKVVKCRFP-VVENGKQISGFGKKFYYKATVMFECDKGFYLDGS----DTIVCDSNSTWDPPVPKCLKV 252 (252)
T ss_dssp EECCCBCCC-CCTTEEEEECCCSCBCTTCEEEEEECTTEEEESC----SEEEECTTSCEESCCCEEEEC
T ss_pred EeeeecCCC-cccCCcEecCCCCccccCCEEEEEeCCCCEEcCC----CcEEECCCCeECCCCCeeeeC
Confidence 99 679987 688998764 345688899999999999999988 889999999999999999875
|
| >1qub_A Protein (human BETA2-glycoprotein I); short consensus repeat, sushi, complement control protein, N glycosylation, multi-domain, membrane adhesion; HET: NAG MAN; 2.70A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1c1z_A* 1g4f_A 1g4g_A 2kri_A 3op8_A | Back alignment and structure |
|---|
| >1ok3_A CD55, CR, DAF, complement decay-accelerating factor; regulator of complement pathway, regulator of complement; 2.2A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1ojw_A 1ojy_A 1ok1_A 1ok2_A 1ojv_A 1ok9_A 1m11_R 1nwv_A 2qzh_A 2qzf_A | Back alignment and structure |
|---|
| >2xrb_A Complement regulatory protein CRRY; immune system, immunology; 2.50A {Rattus norvegicus} PDB: 2xrd_A | Back alignment and structure |
|---|
| >3iyp_F Complement decay-accelerating factor; virus, receptor, complex, echovirus, DAF, icosahedral virus; HET: DAO; 7.20A {Homo sapiens} | Back alignment and structure |
|---|
| >2wii_C H factor 1, complement factor H; immune system, sushi, secreted, polymorphism, glycoprotein, complement system, complement pathway, immune response; HET: NAG BMA; 2.70A {Homo sapiens} PDB: 2rlp_A 2rlq_A | Back alignment and structure |
|---|
| >1ntj_A Complement receptor related protein; immunology, glycoprotein, SCR, CCP, immune system; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
| >1rid_A Complement control protein; regulation, SCR, immune system; HET: IDS SGN; 2.10A {Vaccinia virus} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1g44_A 1g40_A* 1y8e_A* 1e5g_A 1vvc_A 1vvd_A 1vve_A | Back alignment and structure |
|---|
| >1ntj_A Complement receptor related protein; immunology, glycoprotein, SCR, CCP, immune system; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
| >1ntl_A CRRY-IG; immunology, complement, glycoprotein, SCR, CCP, immune system; NMR {Mus musculus} | Back alignment and structure |
|---|
| >1qub_A Protein (human BETA2-glycoprotein I); short consensus repeat, sushi, complement control protein, N glycosylation, multi-domain, membrane adhesion; HET: NAG MAN; 2.70A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1c1z_A* 1g4f_A 1g4g_A 2kri_A 3op8_A | Back alignment and structure |
|---|
| >1ntl_A CRRY-IG; immunology, complement, glycoprotein, SCR, CCP, immune system; NMR {Mus musculus} | Back alignment and structure |
|---|
| >3erb_A Complement C2; C3/C5 convertase, short consensus repeat(SCR), sushi domain, human complement system, complement second component C2; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >3o8e_B Membrane cofactor protein; short consensus repeat, complement control protein, fiber KN virus-receptor interaction, cell adhesion-immunity complex; HET: NAG; 2.84A {Homo sapiens} PDB: 2o39_C* 1ckl_A* 3inb_C* 3l89_M* | Back alignment and structure |
|---|
| >2wii_C H factor 1, complement factor H; immune system, sushi, secreted, polymorphism, glycoprotein, complement system, complement pathway, immune response; HET: NAG BMA; 2.70A {Homo sapiens} PDB: 2rlp_A 2rlq_A | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2gsx_A Complement receptor type 2; SCR domain, CCP domain, sushi domain, immune system; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3sw0_X H factor 1, complement factor H; innate immune response, sushi domains, cofactor in the inact of C3B, C3B, human plasma, immune system; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A | Back alignment and structure |
|---|
| >1rid_A Complement control protein; regulation, SCR, immune system; HET: IDS SGN; 2.10A {Vaccinia virus} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1g44_A 1g40_A* 1y8e_A* 1e5g_A 1vvc_A 1vvd_A 1vve_A | Back alignment and structure |
|---|
| >1ok3_A CD55, CR, DAF, complement decay-accelerating factor; regulator of complement pathway, regulator of complement; 2.2A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 g.18.1.1 g.18.1.1 PDB: 1ojw_A 1ojy_A 1ok1_A 1ok2_A 1ojv_A 1ok9_A 1m11_R 1nwv_A 2qzh_A 2qzf_A | Back alignment and structure |
|---|
| >1haq_A Complement factor H; immunology, glycoprotein, complement alternate pathway, SCR, CCP; NMR {Homo sapiens} PDB: 3gau_A 3gav_A 3gaw_A 2qfh_A 2qfg_A 1hfh_A 2kms_A 1hfi_A 1hcc_A | Back alignment and structure |
|---|
| >2xrb_A Complement regulatory protein CRRY; immune system, immunology; 2.50A {Rattus norvegicus} PDB: 2xrd_A | Back alignment and structure |
|---|
| >2uwn_A H factor 1, human complement factor H; alternative splicing, sucrose octasulphate, AGE-related macular degeneration, complement alternate pathway; HET: SCR; 2.35A {Homo sapiens} PDB: 2v8e_A* 2ic4_A 2w80_A 2w81_A 2jgw_A 2jgx_A | Back alignment and structure |
|---|
| >3hrz_D Complement factor B; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Homo sapiens} PDB: 2xwj_I* 3hs0_D* 2ok5_A* 2xwb_F* | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3iyp_F Complement decay-accelerating factor; virus, receptor, complex, echovirus, DAF, icosahedral virus; HET: DAO; 7.20A {Homo sapiens} | Back alignment and structure |
|---|
| >2q7z_A Complement receptor type 1; SCR domain, blood group antigen, complement pathway, glycoprotein, immune response, innate immunity, membrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3erb_A Complement C2; C3/C5 convertase, short consensus repeat(SCR), sushi domain, human complement system, complement second component C2; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >3gov_A MAsp-1; complement, serine protease, beta barrel, hydrolase, hydroxy immune response, innate immunity, sushi, coagulation, compl pathway; 2.55A {Homo sapiens} PDB: 4djz_A | Back alignment and structure |
|---|
| >2qy0_A Complement C1R subcomponent; serine protease, beta barrel, complement pathway like domain, glycoprotein, hydrolase, hydroxylation, immune response; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
| >1gkn_A Complement receptor type 1; module, SCR, structure; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 | Back alignment and structure |
|---|
| >1gkg_A Complement receptor type 1; module, SCR, structure, sushi; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1ppq_A | Back alignment and structure |
|---|
| >3hrz_D Complement factor B; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Homo sapiens} PDB: 2xwj_I* 3hs0_D* 2ok5_A* 2xwb_F* | Back alignment and structure |
|---|
| >3t5o_A Complement component C6; macpf, MAC, membrane attack complex, innate IMMU system, blood, membrane, cytolysin, immune SYST; HET: NAG FUL FUC BGC MAN; 2.87A {Homo sapiens} PDB: 4a5w_B* 4e0s_B* | Back alignment and structure |
|---|
| >1ly2_A CD21, complement receptor type 2; epstein BARR virus, regulator of comple activation, short consensus repeat, viral receptor; HET: NAG; 1.80A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1w2r_A 1w2s_B 1ghq_B* 3oed_C | Back alignment and structure |
|---|
| >1gkn_A Complement receptor type 1; module, SCR, structure; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 | Back alignment and structure |
|---|
| >2uwn_A H factor 1, human complement factor H; alternative splicing, sucrose octasulphate, AGE-related macular degeneration, complement alternate pathway; HET: SCR; 2.35A {Homo sapiens} PDB: 2v8e_A* 2ic4_A 2w80_A 2w81_A 2jgw_A 2jgx_A | Back alignment and structure |
|---|
| >1h03_P Complement decay-accelerating factor; immune system protein, enteroviral receptor, bacterial receptor, ligand for CD97, complement pathway; 1.7A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1h2q_P 1uot_P 1upn_E 1h2p_P 1h04_P 2qzd_A | Back alignment and structure |
|---|
| >1h03_P Complement decay-accelerating factor; immune system protein, enteroviral receptor, bacterial receptor, ligand for CD97, complement pathway; 1.7A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1h2q_P 1uot_P 1upn_E 1h2p_P 1h04_P 2qzd_A | Back alignment and structure |
|---|
| >1gkg_A Complement receptor type 1; module, SCR, structure, sushi; NMR {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1ppq_A | Back alignment and structure |
|---|
| >1ly2_A CD21, complement receptor type 2; epstein BARR virus, regulator of comple activation, short consensus repeat, viral receptor; HET: NAG; 1.80A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 1w2r_A 1w2s_B 1ghq_B* 3oed_C | Back alignment and structure |
|---|
| >3gov_A MAsp-1; complement, serine protease, beta barrel, hydrolase, hydroxy immune response, innate immunity, sushi, coagulation, compl pathway; 2.55A {Homo sapiens} PDB: 4djz_A | Back alignment and structure |
|---|
| >3t5o_A Complement component C6; macpf, MAC, membrane attack complex, innate IMMU system, blood, membrane, cytolysin, immune SYST; HET: NAG FUL FUC BGC MAN; 2.87A {Homo sapiens} PDB: 4a5w_B* 4e0s_B* | Back alignment and structure |
|---|
| >2a55_A C4B-binding protein; complement, SCR, CCP module, immune system; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2qy0_A Complement C1R subcomponent; serine protease, beta barrel, complement pathway like domain, glycoprotein, hydrolase, hydroxylation, immune response; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
| >2aty_A Complement receptor chimeric conjugate CR2-IG; immunoglobulin fold, antibody, immune system; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3sw0_X H factor 1, complement factor H; innate immune response, sushi domains, cofactor in the inact of C3B, C3B, human plasma, immune system; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >2a55_A C4B-binding protein; complement, SCR, CCP module, immune system; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1zjk_A Mannan-binding lectin serine protease 2; beta barrel, modular protein, hydrolase; 2.18A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 PDB: 1q3x_A | Back alignment and structure |
|---|
| >3r62_A H factor 1, complement factor H; immunity, repeating sushi domain, regulator of C activation, C3D, immune system; 1.52A {Homo sapiens} PDB: 2bzm_A 3oxu_D 3rj3_D 2g7i_A 3kxv_A 3kzj_A 2xqw_C | Back alignment and structure |
|---|
| >3r62_A H factor 1, complement factor H; immunity, repeating sushi domain, regulator of C activation, C3D, immune system; 1.52A {Homo sapiens} PDB: 2bzm_A 3oxu_D 3rj3_D 2g7i_A 3kxv_A 3kzj_A 2xqw_C | Back alignment and structure |
|---|
| >2aty_A Complement receptor chimeric conjugate CR2-IG; immunoglobulin fold, antibody, immune system; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2yby_A Complement factor H; immune system, complement regulation, innate immunity, infec; 1.58A {Mus musculus} | Back alignment and structure |
|---|
| >2yby_A Complement factor H; immune system, complement regulation, innate immunity, infec; 1.58A {Mus musculus} | Back alignment and structure |
|---|
| >4ayi_A H factor 1, complement factor H; immune system, antigens; 2.31A {Homo sapiens} PDB: 4aye_A 4ayd_A 4aym_A 2w80_A 2w81_A 2jgw_A 2jgx_A | Back alignment and structure |
|---|
| >4ayi_A H factor 1, complement factor H; immune system, antigens; 2.31A {Homo sapiens} PDB: 4aye_A 4ayd_A 4aym_A 2w80_A 2w81_A 2jgw_A 2jgx_A | Back alignment and structure |
|---|
| >1zjk_A Mannan-binding lectin serine protease 2; beta barrel, modular protein, hydrolase; 2.18A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 PDB: 1q3x_A | Back alignment and structure |
|---|
| >1gpz_A Complement C1R component; hydrolase, activation, innate immunity, modular structure, serine protease; HET: NAG FUC MAN; 2.9A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 | Back alignment and structure |
|---|
| >2b5i_D Interleukin-2 receptor alpha chain; four-helix bundle, fibronectin domain, cytokine-cytokine REC complex; HET: NAG; 2.30A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 3nfp_I 3iu3_I 1z92_B 2erj_A* | Back alignment and structure |
|---|
| >2ehf_A CUB and sushi domain-containing protein 1; CUB and sushi multiple domains protein 1, CSMD1, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2ehf_A CUB and sushi domain-containing protein 1; CUB and sushi multiple domains protein 1, CSMD1, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1gpz_A Complement C1R component; hydrolase, activation, innate immunity, modular structure, serine protease; HET: NAG FUC MAN; 2.9A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 g.18.1.1 | Back alignment and structure |
|---|
| >2b5i_D Interleukin-2 receptor alpha chain; four-helix bundle, fibronectin domain, cytokine-cytokine REC complex; HET: NAG; 2.30A {Homo sapiens} SCOP: g.18.1.1 g.18.1.1 PDB: 3nfp_I 3iu3_I 1z92_B 2erj_A* | Back alignment and structure |
|---|
| >2yra_A Seizure 6-like protein isoform 3; disulfide bond, sushi domain, SCR, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2yra_A Seizure 6-like protein isoform 3; disulfide bond, sushi domain, SCR, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3tvj_A Mannan-binding lectin serine protease 2 A chain; in vitro evolution, specific inhibitor, allostery, hydrolase; 1.28A {Homo sapiens} | Back alignment and structure |
|---|
| >3tvj_A Mannan-binding lectin serine protease 2 A chain; in vitro evolution, specific inhibitor, allostery, hydrolase; 1.28A {Homo sapiens} | Back alignment and structure |
|---|
| >1srz_A Gamma-aminobutyric acid type B receptor, subunit 1; GABA(B) receptor, CIS-trans isomerization, CCP module, sushi domain; NMR {Rattus norvegicus} SCOP: g.18.1.1 PDB: 1ss2_A | Back alignment and structure |
|---|
| >1srz_A Gamma-aminobutyric acid type B receptor, subunit 1; GABA(B) receptor, CIS-trans isomerization, CCP module, sushi domain; NMR {Rattus norvegicus} SCOP: g.18.1.1 PDB: 1ss2_A | Back alignment and structure |
|---|
| >4aqb_A Mannan-binding lectin serine protease 1; blood clotting, mannan-binding protein, complement, ficolins complement pathway, mannose- binding lectin; HET: NAG BMA MAN; 4.20A {Homo sapiens} | Back alignment and structure |
|---|
| >4aqb_A Mannan-binding lectin serine protease 1; blood clotting, mannan-binding protein, complement, ficolins complement pathway, mannose- binding lectin; HET: NAG BMA MAN; 4.20A {Homo sapiens} | Back alignment and structure |
|---|
| >2psm_F Interleukin-15 receptor alpha chain; cytokine, glycoprotein, secreted, alternative splicing, endoplasmic reticulum, golgi apparatus, membrane; 2.19A {Mus musculus} SCOP: g.18.1.1 | Back alignment and structure |
|---|
| >2psm_F Interleukin-15 receptor alpha chain; cytokine, glycoprotein, secreted, alternative splicing, endoplasmic reticulum, golgi apparatus, membrane; 2.19A {Mus musculus} SCOP: g.18.1.1 | Back alignment and structure |
|---|
| >1elv_A Complement C1S component; trypsin-like serin protease, CCP (OR sushi or SCR)module, HY; HET: NAG FUC NES; 1.70A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 | Back alignment and structure |
|---|
| >2z3q_B Interleukin-15 receptor alpha chain; protein-protein complex, cytokine/cytokine receptor complex; 1.85A {Homo sapiens} SCOP: g.18.1.1 PDB: 2z3r_B 2ers_A | Back alignment and structure |
|---|
| >2z3q_B Interleukin-15 receptor alpha chain; protein-protein complex, cytokine/cytokine receptor complex; 1.85A {Homo sapiens} SCOP: g.18.1.1 PDB: 2z3r_B 2ers_A | Back alignment and structure |
|---|
| >1elv_A Complement C1S component; trypsin-like serin protease, CCP (OR sushi or SCR)module, HY; HET: NAG FUC NES; 1.70A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 | Back alignment and structure |
|---|
| >4f4o_C Haptoglobin; globin fold, serine protease fold, complement control protei haemoglobin scavenging, oxygen storage-transport complex; HET: HEM NAG FUC; 2.90A {Sus scrofa} | Back alignment and structure |
|---|
| >4f4o_C Haptoglobin; globin fold, serine protease fold, complement control protei haemoglobin scavenging, oxygen storage-transport complex; HET: HEM NAG FUC; 2.90A {Sus scrofa} | Back alignment and structure |
|---|
| >1md8_A C1R complement serine protease; innate immunity, activation, substrate specificity, hydrolase; 2.80A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 PDB: 1md7_A* | Back alignment and structure |
|---|
| >1md8_A C1R complement serine protease; innate immunity, activation, substrate specificity, hydrolase; 2.80A {Homo sapiens} SCOP: b.47.1.2 g.18.1.1 PDB: 1md7_A* | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 222 | ||||
| d2ok5a2 | 62 | g.18.1.1 (A:138-199) Complement factor B {Human (H | 5e-14 | |
| d2ok5a2 | 62 | g.18.1.1 (A:138-199) Complement factor B {Human (H | 4e-08 | |
| d2ok5a2 | 62 | g.18.1.1 (A:138-199) Complement factor B {Human (H | 2e-07 | |
| d2ok5a3 | 61 | g.18.1.1 (A:77-137) Complement factor B {Human (Ho | 3e-13 | |
| d2ok5a3 | 61 | g.18.1.1 (A:77-137) Complement factor B {Human (Ho | 1e-09 | |
| d2ok5a3 | 61 | g.18.1.1 (A:77-137) Complement factor B {Human (Ho | 1e-09 | |
| d1quba4 | 60 | g.18.1.1 (A:184-243) beta2-glycoprotein I {Human ( | 4e-12 | |
| d1quba4 | 60 | g.18.1.1 (A:184-243) beta2-glycoprotein I {Human ( | 3e-07 | |
| d1quba4 | 60 | g.18.1.1 (A:184-243) beta2-glycoprotein I {Human ( | 2e-06 | |
| d1quba2 | 58 | g.18.1.1 (A:63-120) beta2-glycoprotein I {Human (H | 3e-11 | |
| d1quba2 | 58 | g.18.1.1 (A:63-120) beta2-glycoprotein I {Human (H | 1e-07 | |
| d1quba2 | 58 | g.18.1.1 (A:63-120) beta2-glycoprotein I {Human (H | 1e-07 | |
| d1g40a4 | 59 | g.18.1.1 (A:185-243) Complement control protein {V | 4e-11 | |
| d1g40a4 | 59 | g.18.1.1 (A:185-243) Complement control protein {V | 6e-10 | |
| d1g40a4 | 59 | g.18.1.1 (A:185-243) Complement control protein {V | 7e-07 | |
| d1ly2a2 | 63 | g.18.1.1 (A:67-129) Complement receptor 2, cr2 {Hu | 7e-11 | |
| d1ly2a2 | 63 | g.18.1.1 (A:67-129) Complement receptor 2, cr2 {Hu | 3e-09 | |
| d1ly2a2 | 63 | g.18.1.1 (A:67-129) Complement receptor 2, cr2 {Hu | 6e-06 | |
| d2o39c2 | 64 | g.18.1.1 (C:63-126) CD46 (membrane cofactor protei | 1e-10 | |
| d2o39c2 | 64 | g.18.1.1 (C:63-126) CD46 (membrane cofactor protei | 9e-08 | |
| d2o39c2 | 64 | g.18.1.1 (C:63-126) CD46 (membrane cofactor protei | 6e-07 | |
| d1h03p2 | 63 | g.18.1.1 (P:67-129) Complement decay-accelerating | 2e-10 | |
| d1h03p2 | 63 | g.18.1.1 (P:67-129) Complement decay-accelerating | 5e-08 | |
| d1h03p2 | 63 | g.18.1.1 (P:67-129) Complement decay-accelerating | 1e-07 | |
| d1ly2a1 | 67 | g.18.1.1 (A:0-66) Complement receptor 2, cr2 {Huma | 4e-10 | |
| d1ly2a1 | 67 | g.18.1.1 (A:0-66) Complement receptor 2, cr2 {Huma | 2e-09 | |
| d1ly2a1 | 67 | g.18.1.1 (A:0-66) Complement receptor 2, cr2 {Huma | 1e-06 | |
| d1g40a2 | 62 | g.18.1.1 (A:65-126) Complement control protein {Va | 6e-10 | |
| d1g40a2 | 62 | g.18.1.1 (A:65-126) Complement control protein {Va | 3e-08 | |
| d1g40a2 | 62 | g.18.1.1 (A:65-126) Complement control protein {Va | 8e-07 | |
| d1h03p1 | 62 | g.18.1.1 (P:5-66) Complement decay-accelerating fa | 1e-09 | |
| d1h03p1 | 62 | g.18.1.1 (P:5-66) Complement decay-accelerating fa | 9e-07 | |
| d1h03p1 | 62 | g.18.1.1 (P:5-66) Complement decay-accelerating fa | 3e-05 | |
| d1quba1 | 62 | g.18.1.1 (A:1-62) beta2-glycoprotein I {Human (Hom | 2e-09 | |
| d1quba1 | 62 | g.18.1.1 (A:1-62) beta2-glycoprotein I {Human (Hom | 7e-07 | |
| d1quba1 | 62 | g.18.1.1 (A:1-62) beta2-glycoprotein I {Human (Hom | 2e-05 | |
| d1g40a3 | 58 | g.18.1.1 (A:127-184) Complement control protein {V | 2e-09 | |
| d1g40a3 | 58 | g.18.1.1 (A:127-184) Complement control protein {V | 8e-07 | |
| d1g40a3 | 58 | g.18.1.1 (A:127-184) Complement control protein {V | 2e-05 | |
| d1hfia_ | 62 | g.18.1.1 (A:) Factor H, 15th and 16th modules {Hum | 3e-09 | |
| d1hfia_ | 62 | g.18.1.1 (A:) Factor H, 15th and 16th modules {Hum | 9e-05 | |
| d1hfia_ | 62 | g.18.1.1 (A:) Factor H, 15th and 16th modules {Hum | 6e-04 | |
| d1quba3 | 63 | g.18.1.1 (A:121-183) beta2-glycoprotein I {Human ( | 4e-09 | |
| d1quba3 | 63 | g.18.1.1 (A:121-183) beta2-glycoprotein I {Human ( | 2e-05 | |
| d1quba3 | 63 | g.18.1.1 (A:121-183) beta2-glycoprotein I {Human ( | 3e-05 | |
| d1srza_ | 68 | g.18.1.1 (A:) GABA-B receptor 1 {Rat (Rattus norve | 6e-09 | |
| d1srza_ | 68 | g.18.1.1 (A:) GABA-B receptor 1 {Rat (Rattus norve | 2e-06 | |
| d1srza_ | 68 | g.18.1.1 (A:) GABA-B receptor 1 {Rat (Rattus norve | 0.001 | |
| d1ppqa_ | 68 | g.18.1.1 (A:) Complement receptor 1, cr1 {Human (H | 8e-09 | |
| d1ppqa_ | 68 | g.18.1.1 (A:) Complement receptor 1, cr1 {Human (H | 8e-06 | |
| d1ppqa_ | 68 | g.18.1.1 (A:) Complement receptor 1, cr1 {Human (H | 2e-05 | |
| d1hcca_ | 59 | g.18.1.1 (A:) Factor H, 15th and 16th modules {Hum | 9e-09 | |
| d1hcca_ | 59 | g.18.1.1 (A:) Factor H, 15th and 16th modules {Hum | 9e-07 | |
| d1hcca_ | 59 | g.18.1.1 (A:) Factor H, 15th and 16th modules {Hum | 8e-06 | |
| d1gpza2 | 68 | g.18.1.1 (A:290-357) Complement C1R protease domai | 2e-08 | |
| d1gpza2 | 68 | g.18.1.1 (A:290-357) Complement C1R protease domai | 7e-08 | |
| d1gpza2 | 68 | g.18.1.1 (A:290-357) Complement C1R protease domai | 1e-04 | |
| d1zjka2 | 53 | g.18.1.1 (A:311-363) Complement C1R protease domai | 3e-07 | |
| d1zjka2 | 53 | g.18.1.1 (A:311-363) Complement C1R protease domai | 4e-06 | |
| d1zjka2 | 53 | g.18.1.1 (A:311-363) Complement C1R protease domai | 1e-05 | |
| d1gkna1 | 64 | g.18.1.1 (A:897-960) Complement receptor 1, cr1 {H | 4e-07 | |
| d1gkna1 | 64 | g.18.1.1 (A:897-960) Complement receptor 1, cr1 {H | 3e-05 | |
| d1ok3a2 | 64 | g.18.1.1 (A:65-128) Complement decay-accelerating | 1e-06 | |
| d1ok3a2 | 64 | g.18.1.1 (A:65-128) Complement decay-accelerating | 3e-05 | |
| d1ok3a1 | 64 | g.18.1.1 (A:1-64) Complement decay-accelerating fa | 3e-06 | |
| d1ok3a1 | 64 | g.18.1.1 (A:1-64) Complement decay-accelerating fa | 8e-06 | |
| d2o39c1 | 62 | g.18.1.1 (C:1-62) CD46 (membrane cofactor protein, | 6e-06 | |
| d2o39c1 | 62 | g.18.1.1 (C:1-62) CD46 (membrane cofactor protein, | 2e-04 | |
| d1gkga2 | 70 | g.18.1.1 (A:1023-1092) Complement receptor 1, cr1 | 7e-06 | |
| d1gkga2 | 70 | g.18.1.1 (A:1023-1092) Complement receptor 1, cr1 | 8e-05 | |
| d1q3xa2 | 75 | g.18.1.1 (A:366-440) Mannan-binding lectin serine | 8e-06 | |
| d1q3xa2 | 75 | g.18.1.1 (A:366-440) Mannan-binding lectin serine | 2e-04 | |
| d1md8a2 | 76 | g.18.1.1 (A:358-433) Complement C1R protease domai | 2e-05 | |
| d1md8a2 | 76 | g.18.1.1 (A:358-433) Complement C1R protease domai | 7e-05 | |
| d1elva2 | 68 | g.18.1.1 (A:342-409) Complement C1S protease domai | 3e-04 | |
| d1elva2 | 68 | g.18.1.1 (A:342-409) Complement C1S protease domai | 0.001 | |
| d2z3qb1 | 78 | g.18.1.1 (B:1-78) Interleukin-15 receptor subunit | 5e-04 | |
| d2z3qb1 | 78 | g.18.1.1 (B:1-78) Interleukin-15 receptor subunit | 6e-04 |
| >d2ok5a2 g.18.1.1 (A:138-199) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
class: Small proteins fold: Complement control module/SCR domain superfamily: Complement control module/SCR domain family: Complement control module/SCR domain domain: Complement factor B species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.2 bits (151), Expect = 5e-14
Identities = 17/65 (26%), Positives = 26/65 (40%), Gaps = 4/65 (6%)
Query: 95 HCPVPALPLNGHLIEDPTGGPYRVGAILQFACNDRHHLLGEETIVCTETGRWSRAPPRCK 154
+C P +P+ G YR+ + + C+ L G + C E G WS P C+
Sbjct: 2 YCSNPGIPIGTRK----VGSQYRLEDSVTYHCSRGLTLRGSQRRTCQEGGSWSGTEPSCQ 57
Query: 155 ARCEY 159
Y
Sbjct: 58 DSFMY 62
|
| >d2ok5a2 g.18.1.1 (A:138-199) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d2ok5a2 g.18.1.1 (A:138-199) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d2ok5a3 g.18.1.1 (A:77-137) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} Length = 61 | Back information, alignment and structure |
|---|
| >d2ok5a3 g.18.1.1 (A:77-137) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} Length = 61 | Back information, alignment and structure |
|---|
| >d2ok5a3 g.18.1.1 (A:77-137) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} Length = 61 | Back information, alignment and structure |
|---|
| >d1quba4 g.18.1.1 (A:184-243) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 60 | Back information, alignment and structure |
|---|
| >d1quba4 g.18.1.1 (A:184-243) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 60 | Back information, alignment and structure |
|---|
| >d1quba4 g.18.1.1 (A:184-243) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 60 | Back information, alignment and structure |
|---|
| >d1quba2 g.18.1.1 (A:63-120) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 58 | Back information, alignment and structure |
|---|
| >d1quba2 g.18.1.1 (A:63-120) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 58 | Back information, alignment and structure |
|---|
| >d1quba2 g.18.1.1 (A:63-120) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 58 | Back information, alignment and structure |
|---|
| >d1g40a4 g.18.1.1 (A:185-243) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 59 | Back information, alignment and structure |
|---|
| >d1g40a4 g.18.1.1 (A:185-243) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 59 | Back information, alignment and structure |
|---|
| >d1g40a4 g.18.1.1 (A:185-243) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 59 | Back information, alignment and structure |
|---|
| >d1ly2a2 g.18.1.1 (A:67-129) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d1ly2a2 g.18.1.1 (A:67-129) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d1ly2a2 g.18.1.1 (A:67-129) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d2o39c2 g.18.1.1 (C:63-126) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d2o39c2 g.18.1.1 (C:63-126) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d2o39c2 g.18.1.1 (C:63-126) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d1h03p2 g.18.1.1 (P:67-129) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d1h03p2 g.18.1.1 (P:67-129) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d1h03p2 g.18.1.1 (P:67-129) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d1ly2a1 g.18.1.1 (A:0-66) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} Length = 67 | Back information, alignment and structure |
|---|
| >d1ly2a1 g.18.1.1 (A:0-66) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} Length = 67 | Back information, alignment and structure |
|---|
| >d1ly2a1 g.18.1.1 (A:0-66) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} Length = 67 | Back information, alignment and structure |
|---|
| >d1g40a2 g.18.1.1 (A:65-126) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 62 | Back information, alignment and structure |
|---|
| >d1g40a2 g.18.1.1 (A:65-126) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 62 | Back information, alignment and structure |
|---|
| >d1g40a2 g.18.1.1 (A:65-126) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 62 | Back information, alignment and structure |
|---|
| >d1h03p1 g.18.1.1 (P:5-66) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1h03p1 g.18.1.1 (P:5-66) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1h03p1 g.18.1.1 (P:5-66) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1quba1 g.18.1.1 (A:1-62) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1quba1 g.18.1.1 (A:1-62) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1quba1 g.18.1.1 (A:1-62) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1g40a3 g.18.1.1 (A:127-184) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 58 | Back information, alignment and structure |
|---|
| >d1g40a3 g.18.1.1 (A:127-184) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 58 | Back information, alignment and structure |
|---|
| >d1g40a3 g.18.1.1 (A:127-184) Complement control protein {Vaccinia virus [TaxId: 10245]} Length = 58 | Back information, alignment and structure |
|---|
| >d1hfia_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1hfia_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1hfia_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1quba3 g.18.1.1 (A:121-183) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d1quba3 g.18.1.1 (A:121-183) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d1quba3 g.18.1.1 (A:121-183) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
| >d1srza_ g.18.1.1 (A:) GABA-B receptor 1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 68 | Back information, alignment and structure |
|---|
| >d1srza_ g.18.1.1 (A:) GABA-B receptor 1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 68 | Back information, alignment and structure |
|---|
| >d1srza_ g.18.1.1 (A:) GABA-B receptor 1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 68 | Back information, alignment and structure |
|---|
| >d1ppqa_ g.18.1.1 (A:) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
| >d1ppqa_ g.18.1.1 (A:) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
| >d1ppqa_ g.18.1.1 (A:) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
| >d1hcca_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} Length = 59 | Back information, alignment and structure |
|---|
| >d1hcca_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} Length = 59 | Back information, alignment and structure |
|---|
| >d1hcca_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} Length = 59 | Back information, alignment and structure |
|---|
| >d1gpza2 g.18.1.1 (A:290-357) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
| >d1gpza2 g.18.1.1 (A:290-357) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
| >d1gpza2 g.18.1.1 (A:290-357) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
| >d1zjka2 g.18.1.1 (A:311-363) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} Length = 53 | Back information, alignment and structure |
|---|
| >d1zjka2 g.18.1.1 (A:311-363) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} Length = 53 | Back information, alignment and structure |
|---|
| >d1zjka2 g.18.1.1 (A:311-363) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} Length = 53 | Back information, alignment and structure |
|---|
| >d1gkna1 g.18.1.1 (A:897-960) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d1gkna1 g.18.1.1 (A:897-960) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d1ok3a2 g.18.1.1 (A:65-128) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d1ok3a2 g.18.1.1 (A:65-128) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d1ok3a1 g.18.1.1 (A:1-64) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d1ok3a1 g.18.1.1 (A:1-64) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
| >d2o39c1 g.18.1.1 (C:1-62) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d2o39c1 g.18.1.1 (C:1-62) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
| >d1gkga2 g.18.1.1 (A:1023-1092) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} Length = 70 | Back information, alignment and structure |
|---|
| >d1gkga2 g.18.1.1 (A:1023-1092) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} Length = 70 | Back information, alignment and structure |
|---|
| >d1q3xa2 g.18.1.1 (A:366-440) Mannan-binding lectin serine protease 2 (MASP-2) domains {Human (Homo sapiens) [TaxId: 9606]} Length = 75 | Back information, alignment and structure |
|---|
| >d1q3xa2 g.18.1.1 (A:366-440) Mannan-binding lectin serine protease 2 (MASP-2) domains {Human (Homo sapiens) [TaxId: 9606]} Length = 75 | Back information, alignment and structure |
|---|
| >d1md8a2 g.18.1.1 (A:358-433) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} Length = 76 | Back information, alignment and structure |
|---|
| >d1md8a2 g.18.1.1 (A:358-433) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} Length = 76 | Back information, alignment and structure |
|---|
| >d1elva2 g.18.1.1 (A:342-409) Complement C1S protease domain {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
| >d1elva2 g.18.1.1 (A:342-409) Complement C1S protease domain {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
| >d2z3qb1 g.18.1.1 (B:1-78) Interleukin-15 receptor subunit alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 78 | Back information, alignment and structure |
|---|
| >d2z3qb1 g.18.1.1 (B:1-78) Interleukin-15 receptor subunit alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 78 | Back information, alignment and structure |
|---|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 222 | |||
| d2ok5a3 | 61 | Complement factor B {Human (Homo sapiens) [TaxId: | 99.52 | |
| d1quba2 | 58 | beta2-glycoprotein I {Human (Homo sapiens) [TaxId: | 99.52 | |
| d2ok5a3 | 61 | Complement factor B {Human (Homo sapiens) [TaxId: | 99.51 | |
| d1q3xa2 | 75 | Mannan-binding lectin serine protease 2 (MASP-2) d | 99.5 | |
| d1g40a3 | 58 | Complement control protein {Vaccinia virus [TaxId: | 99.5 | |
| d1ly2a1 | 67 | Complement receptor 2, cr2 {Human (Homo sapiens) [ | 99.5 | |
| d1quba2 | 58 | beta2-glycoprotein I {Human (Homo sapiens) [TaxId: | 99.49 | |
| d1ly2a2 | 63 | Complement receptor 2, cr2 {Human (Homo sapiens) [ | 99.49 | |
| d1ly2a1 | 67 | Complement receptor 2, cr2 {Human (Homo sapiens) [ | 99.49 | |
| d1gpza2 | 68 | Complement C1R protease domains {Human (Homo sapie | 99.48 | |
| d2ok5a2 | 62 | Complement factor B {Human (Homo sapiens) [TaxId: | 99.48 | |
| d1quba1 | 62 | beta2-glycoprotein I {Human (Homo sapiens) [TaxId: | 99.48 | |
| d1quba4 | 60 | beta2-glycoprotein I {Human (Homo sapiens) [TaxId: | 99.47 | |
| d1hcca_ | 59 | Factor H, 15th and 16th modules {Human (Homo sapie | 99.46 | |
| d1g40a3 | 58 | Complement control protein {Vaccinia virus [TaxId: | 99.46 | |
| d2o39c2 | 64 | CD46 (membrane cofactor protein, MCP) {Human (Homo | 99.46 | |
| d1quba3 | 63 | beta2-glycoprotein I {Human (Homo sapiens) [TaxId: | 99.46 | |
| d1gpza2 | 68 | Complement C1R protease domains {Human (Homo sapie | 99.46 | |
| d1g40a4 | 59 | Complement control protein {Vaccinia virus [TaxId: | 99.45 | |
| d2ok5a2 | 62 | Complement factor B {Human (Homo sapiens) [TaxId: | 99.45 | |
| d1h03p2 | 63 | Complement decay-accelerating factor (Daf, CD55) { | 99.45 | |
| d1quba4 | 60 | beta2-glycoprotein I {Human (Homo sapiens) [TaxId: | 99.45 | |
| d2o39c2 | 64 | CD46 (membrane cofactor protein, MCP) {Human (Homo | 99.45 | |
| d1quba1 | 62 | beta2-glycoprotein I {Human (Homo sapiens) [TaxId: | 99.44 | |
| d1hfia_ | 62 | Factor H, 15th and 16th modules {Human (Homo sapie | 99.43 | |
| d1quba3 | 63 | beta2-glycoprotein I {Human (Homo sapiens) [TaxId: | 99.43 | |
| d1ly2a2 | 63 | Complement receptor 2, cr2 {Human (Homo sapiens) [ | 99.42 | |
| d1md8a2 | 76 | Complement C1R protease domains {Human (Homo sapie | 99.41 | |
| d1hfia_ | 62 | Factor H, 15th and 16th modules {Human (Homo sapie | 99.41 | |
| d1ppqa_ | 68 | Complement receptor 1, cr1 {Human (Homo sapiens) [ | 99.41 | |
| d1hcca_ | 59 | Factor H, 15th and 16th modules {Human (Homo sapie | 99.4 | |
| d1g40a2 | 62 | Complement control protein {Vaccinia virus [TaxId: | 99.4 | |
| d1h03p2 | 63 | Complement decay-accelerating factor (Daf, CD55) { | 99.39 | |
| d1g40a2 | 62 | Complement control protein {Vaccinia virus [TaxId: | 99.39 | |
| d1ok3a2 | 64 | Complement decay-accelerating factor (Daf, CD55) { | 99.39 | |
| d1gkna1 | 64 | Complement receptor 1, cr1 {Human (Homo sapiens) [ | 99.38 | |
| d1q3xa2 | 75 | Mannan-binding lectin serine protease 2 (MASP-2) d | 99.37 | |
| d1ok3a2 | 64 | Complement decay-accelerating factor (Daf, CD55) { | 99.37 | |
| d1md8a2 | 76 | Complement C1R protease domains {Human (Homo sapie | 99.37 | |
| d1ok3a1 | 64 | Complement decay-accelerating factor (Daf, CD55) { | 99.36 | |
| d1h03p1 | 62 | Complement decay-accelerating factor (Daf, CD55) { | 99.35 | |
| d1g40a4 | 59 | Complement control protein {Vaccinia virus [TaxId: | 99.35 | |
| d1ppqa_ | 68 | Complement receptor 1, cr1 {Human (Homo sapiens) [ | 99.34 | |
| d1elva2 | 68 | Complement C1S protease domain {Human (Homo sapien | 99.32 | |
| d1gkga2 | 70 | Complement receptor 1, cr1 {Human (Homo sapiens) [ | 99.32 | |
| d1zjka2 | 53 | Complement C1R protease domains {Human (Homo sapie | 99.32 | |
| d1elva2 | 68 | Complement C1S protease domain {Human (Homo sapien | 99.32 | |
| d1ok3a1 | 64 | Complement decay-accelerating factor (Daf, CD55) { | 99.31 | |
| d1gkga2 | 70 | Complement receptor 1, cr1 {Human (Homo sapiens) [ | 99.31 | |
| d1h03p1 | 62 | Complement decay-accelerating factor (Daf, CD55) { | 99.3 | |
| d2z3qb1 | 78 | Interleukin-15 receptor subunit alpha {Human (Homo | 99.28 | |
| d2o39c1 | 62 | CD46 (membrane cofactor protein, MCP) {Human (Homo | 99.27 | |
| d1gkna1 | 64 | Complement receptor 1, cr1 {Human (Homo sapiens) [ | 99.26 | |
| d2z3qb1 | 78 | Interleukin-15 receptor subunit alpha {Human (Homo | 99.24 | |
| d1zjka2 | 53 | Complement C1R protease domains {Human (Homo sapie | 99.24 | |
| d2o39c1 | 62 | CD46 (membrane cofactor protein, MCP) {Human (Homo | 99.23 | |
| d1srza_ | 68 | GABA-B receptor 1 {Rat (Rattus norvegicus) [TaxId: | 99.22 | |
| d1srza_ | 68 | GABA-B receptor 1 {Rat (Rattus norvegicus) [TaxId: | 99.22 | |
| d2ok5a4 | 68 | Complement factor B {Human (Homo sapiens) [TaxId: | 97.77 | |
| d2b5id2 | 63 | Interleukin-2 receptor alpha chain {Human (Homo sa | 97.71 | |
| d2ok5a4 | 68 | Complement factor B {Human (Homo sapiens) [TaxId: | 97.58 | |
| d2b5id2 | 63 | Interleukin-2 receptor alpha chain {Human (Homo sa | 97.51 | |
| d1g40a1 | 64 | Complement control protein {Vaccinia virus [TaxId: | 96.69 | |
| d1g40a1 | 64 | Complement control protein {Vaccinia virus [TaxId: | 95.86 | |
| d2b5id1 | 64 | Interleukin-2 receptor alpha chain {Human (Homo sa | 95.52 | |
| d2b5id1 | 64 | Interleukin-2 receptor alpha chain {Human (Homo sa | 93.1 | |
| d2joda1 | 106 | Pituitary adenylate cyclase-activating polypeptide | 83.97 |
| >d2ok5a3 g.18.1.1 (A:77-137) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Complement control module/SCR domain superfamily: Complement control module/SCR domain family: Complement control module/SCR domain domain: Complement factor B species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=5.7e-15 Score=91.66 Aligned_cols=58 Identities=31% Similarity=0.566 Sum_probs=53.7
Q ss_pred eCCCCcc-CCCeEEeccCCcccccEEEEEcCCCCeEeCCCceEeCCCCeeeCCCCceec
Q psy14531 24 ICPKIVV-ENPYLTLVEQNNTYRGHAIFQCSWGYQLKGPPDIVCQKNGSWSGAIPECNA 81 (222)
Q Consensus 24 ~C~~p~~-~ng~~~~~~~~~~~g~~~~~~C~~gy~l~G~~~~~C~~~g~W~~~~p~C~~ 81 (222)
.|+.|+. +||.+......|.+|+.|+|+|+.||.|.|+..++|+.+|+|+.+.|.|+.
T Consensus 1 ~Cp~p~~~~nG~~~~~~~~~~~g~~v~y~C~~Gy~l~G~~~~~C~~~g~Ws~~~P~C~d 59 (61)
T d2ok5a3 1 HCPRPHDFENGEYWPRSPYYNVSDEISFHCYDGYTLRGSANRTCQVNGRWSGQTAICDN 59 (61)
T ss_dssp EECCCSCCTTEEEESCCSSEETTCEEEEEECTTCEEESCSEEEBCTTSCBSSCCCEEEC
T ss_pred CccCCCCCCCcEEecCCCcccCCCEEEEECCCCCEEeCCCeeEECCCCeECCCCCeecC
Confidence 3888877 999998777779999999999999999999999999999999999999986
|
| >d1quba2 g.18.1.1 (A:63-120) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2ok5a3 g.18.1.1 (A:77-137) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1q3xa2 g.18.1.1 (A:366-440) Mannan-binding lectin serine protease 2 (MASP-2) domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g40a3 g.18.1.1 (A:127-184) Complement control protein {Vaccinia virus [TaxId: 10245]} | Back information, alignment and structure |
|---|
| >d1ly2a1 g.18.1.1 (A:0-66) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1quba2 g.18.1.1 (A:63-120) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ly2a2 g.18.1.1 (A:67-129) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ly2a1 g.18.1.1 (A:0-66) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gpza2 g.18.1.1 (A:290-357) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2ok5a2 g.18.1.1 (A:138-199) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1quba1 g.18.1.1 (A:1-62) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1quba4 g.18.1.1 (A:184-243) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1hcca_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g40a3 g.18.1.1 (A:127-184) Complement control protein {Vaccinia virus [TaxId: 10245]} | Back information, alignment and structure |
|---|
| >d2o39c2 g.18.1.1 (C:63-126) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1quba3 g.18.1.1 (A:121-183) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gpza2 g.18.1.1 (A:290-357) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g40a4 g.18.1.1 (A:185-243) Complement control protein {Vaccinia virus [TaxId: 10245]} | Back information, alignment and structure |
|---|
| >d2ok5a2 g.18.1.1 (A:138-199) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1h03p2 g.18.1.1 (P:67-129) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1quba4 g.18.1.1 (A:184-243) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2o39c2 g.18.1.1 (C:63-126) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1quba1 g.18.1.1 (A:1-62) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1hfia_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1quba3 g.18.1.1 (A:121-183) beta2-glycoprotein I {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ly2a2 g.18.1.1 (A:67-129) Complement receptor 2, cr2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1md8a2 g.18.1.1 (A:358-433) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1hfia_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ppqa_ g.18.1.1 (A:) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1hcca_ g.18.1.1 (A:) Factor H, 15th and 16th modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g40a2 g.18.1.1 (A:65-126) Complement control protein {Vaccinia virus [TaxId: 10245]} | Back information, alignment and structure |
|---|
| >d1h03p2 g.18.1.1 (P:67-129) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g40a2 g.18.1.1 (A:65-126) Complement control protein {Vaccinia virus [TaxId: 10245]} | Back information, alignment and structure |
|---|
| >d1ok3a2 g.18.1.1 (A:65-128) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gkna1 g.18.1.1 (A:897-960) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1q3xa2 g.18.1.1 (A:366-440) Mannan-binding lectin serine protease 2 (MASP-2) domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ok3a2 g.18.1.1 (A:65-128) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1md8a2 g.18.1.1 (A:358-433) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ok3a1 g.18.1.1 (A:1-64) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1h03p1 g.18.1.1 (P:5-66) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g40a4 g.18.1.1 (A:185-243) Complement control protein {Vaccinia virus [TaxId: 10245]} | Back information, alignment and structure |
|---|
| >d1ppqa_ g.18.1.1 (A:) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1elva2 g.18.1.1 (A:342-409) Complement C1S protease domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gkga2 g.18.1.1 (A:1023-1092) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1zjka2 g.18.1.1 (A:311-363) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1elva2 g.18.1.1 (A:342-409) Complement C1S protease domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ok3a1 g.18.1.1 (A:1-64) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gkga2 g.18.1.1 (A:1023-1092) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1h03p1 g.18.1.1 (P:5-66) Complement decay-accelerating factor (Daf, CD55) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2z3qb1 g.18.1.1 (B:1-78) Interleukin-15 receptor subunit alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2o39c1 g.18.1.1 (C:1-62) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gkna1 g.18.1.1 (A:897-960) Complement receptor 1, cr1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2z3qb1 g.18.1.1 (B:1-78) Interleukin-15 receptor subunit alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1zjka2 g.18.1.1 (A:311-363) Complement C1R protease domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2o39c1 g.18.1.1 (C:1-62) CD46 (membrane cofactor protein, MCP) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1srza_ g.18.1.1 (A:) GABA-B receptor 1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
| >d1srza_ g.18.1.1 (A:) GABA-B receptor 1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
| >d2ok5a4 g.18.1.1 (A:9-76) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2b5id2 g.18.1.1 (D:103-165) Interleukin-2 receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2ok5a4 g.18.1.1 (A:9-76) Complement factor B {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2b5id2 g.18.1.1 (D:103-165) Interleukin-2 receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g40a1 g.18.1.1 (A:1-64) Complement control protein {Vaccinia virus [TaxId: 10245]} | Back information, alignment and structure |
|---|
| >d1g40a1 g.18.1.1 (A:1-64) Complement control protein {Vaccinia virus [TaxId: 10245]} | Back information, alignment and structure |
|---|
| >d2b5id1 g.18.1.1 (D:1-64) Interleukin-2 receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2b5id1 g.18.1.1 (D:1-64) Interleukin-2 receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2joda1 g.76.1.1 (A:17-122) Pituitary adenylate cyclase-activating polypeptide type I receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|